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Fractures repair by two distinct mechanism; indirect fracture healing via an
endochondral stage and direct fracture healing with primary bone formation via
osteonal remodelling units ('cutting cones'). Bisphosphonates are recommended by
national clinical guidelines to reduce the risk of osteoporotic fractures. Despite
bisphosphonate therapy, osteoporotic fractures continue to occur. A proportion of
these fractures require rigid fixation, whereby bone repairs by direct fracture healing.
The effects of bisphosphonate therapy on direct fracture healing have not been
previously reported. With indirect fracture healing, therapeutic doses of
bisphosphonate led to a delay in callus remodelling and a larger callus volume
without detrimental effects on the physical property of healing fractures.
A model of direct fracture healing with rigid tibial plating in the rat was developed.
In addition, a non-rigid model of external fixation that used the same number and
size of screw holes to that of the plating model was used for comparison. Implants
were designed and tested in cadavers prior to preliminary studies in rats.
Within these two groups, animals were randomly allocated either to receive daily
injections of bisphosphonate (Ibandronate) or saline (Control) for nine weeks.
Following three weeks of injections a transverse tibial osteotomy was created and
stabilised. Plain radiographs were obtained at fortnightly intervals. Animals were
sacrificed at six weeks post fracture stabilisation. On sacrifice, fracture healing was
assessed on contact radiographs, with a 4-point bend to failure and histologically.
The mechanical properties of the uninjured diaphyseal bone in the contra-lateral limb
were also assessed following bisphosphonate therapy.
The mean bending stress at failure of diaphyseal bone in the uninjured limb was
increased by 20% following only nine weeks of bisphosphonate treatment. The
increase in strength of the uninjured diaphyseal bone has relevance when normalising
the strength of fracture repair in a limb when comparing it to the unfractured limb as
frequently reported in animal studies of fracture repair.
In direct fracture healing bisphosphonate therapy resulted in impaired fracture
healing as evident on plain radiographs based on the visibility of the fracture line. At
six weeks post fracture the failure stress on application of a 4-point bend was
decreased and histology revealed delayed bone healing compared to controls.
Ibandronate treatment had an inhibitory effect on direct fracture healing in a rodent
model.
In clinical practice, the treating surgeon may need to consider using non-rigid
fixation methods in patients already on bisphosphonate therapy. When rigid fixation
is essential patients on bisphosphonates will need to be monitored for features of
delayed or non-union and the use of fracture healing adjuncts should be considered.
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Figure 1: 'Cutting-cone', (a) Schematic diagram shows cutting cone advancing from
left to right led by multinucleated osteoclast which resorb bone followed by a central
vessel and surface osteoblast synthesising lamellar bone, (b) Photomicrograph of
cutting cone passing through rabbit cortical bone. From Shapiro F, European Cells
and Materials 2008; 15: 53-76 27
Figure 2: (a) Transverse osteotomy in pre-drilled bone and (b) apposition at
osteotomy site 80
Figure 3: Plain radiograph of pilot study at 5 weeks post fracture shows proximal
screw loosening and callus formation 81
Figure 4: Fracture through the 4th screw hole on the narrower area of the tibia distally
when 1.4mm screws used 82
Figure 5: Radiograph 6 weeks post fixation with 12mm x 3mm x 1mm plate revealed
no externa] callus 83
Figure 6: H&E stained coronal section at x5 magnification of tibia fixed with 1mm
thick plate. Note cortical gap on upper surface. This area is opposite the surface of
plate application 83
Figure 7: (a) A-P radiograph of plated tibia, (b) Valgus stress. (c)Varus stress. Note
no widening or translation of osteotomy on stress application 84
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Figure 8: Plain radiographs following plate fixation (12mm x 3mm x 0.4mm) reveal
no external callus, apposition of bone fragments and restoration of tibial alignment,
(a) Immediate post-op (b) 2 wks post-op (c) 4 wks post-op (d) 6 wks post-op 85
Figure 9: Masson's trichrome stain at 6 weeks post rigid compression plate fixation
(a) x4 magnification shows osteotomy fragments aligned with no external callus. On
the upper aspect note 'contact healing'on the cortical surface of plate application and
'gap healing' on the lower cortex opposite plate application, (b) x20 magnification
'contact healing, (c) x20 magnification 'gap healing' with deposition of new bone
parallel to the line of osteotomy. Yellow line scale at 100pm 86
Figure 10: Masson's trichrome at 6 weeks post rigid compression plating (a) x4
magnification with 'cutting cone' (b) x20 magnification. Arrow shows osteonal
remodelling unit traversing osteotomy site. Yellow scale line indicates 100pm 86
Figure 11: 'Cutting-cone' traversing osteotomy site in the rat model of direct fracture
healing developed in this study. Note leading osteoclast on the right and new bone
deposition behind the area of resorption 87
Figure 12: Unrestricted mobilisation post application of external fixator 90
Figure 13: Custom made 4-hole jig. Two holes on lateral surface for threading of fine
wire to help secure jig onto bone. Note there is also also a roughened surface to
prevent the jig slipping on bone during drilling 93
Figure 14: (a) Surgical approach (b) Custom jig (c) 4 drill holes on tibia (d)
Osteotomy creation under saline irrigation 93
Figure 15: Tibial plating showing anatomical alignment and compression at
osteotomy site 94
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Figure 16: Timeline for animal surgery 97
Figure 17: Mechanical testing jig and sequence of 4-point bending test 102
Figure 18: Cross section of tibia. H = external vertical height, B= external base
length, h= inner vertical height, b= inner base length 106
Figure 19: Diagram of 4-point bending with explanation of abbreviations used in
equations to calculate stress, and theoretical strain 107
Figure 20: Rat positioning to obtain standardised antero-posterior radiograph of tibia
Ill
Figure 21: A diagram of the method used to determine callus index 112
Figure 22: X-rays of extricated tibiae demonstrating scoring for visibility of
osteotomy 113
Figure 23: A diagram of method used to measure sagittal callus width 114
Figure 24: Aluminium step wedge with ten, 1 mm steps 115
Figure 25: Serial x-rays of a bisphosphonate treated animal with rigid plate fixation.
Note no external callus formation and anatomical reduction, but persistence of
fracture line 126
Figure 26: Serial x-rays of an animal with external fixator stabilisation of tibial
osteotomy. Note external callus formation 126
Figure 27: Masson's Trichrome (x4) magnification, (a) Control plate fixation. Note
primary healing with bone formation, (b) Bisphosphonate plate fixation. Note little
activity at the fracture site with cartilage formation. Yellow line scale at 100pm... 132
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Figure 28: Masson's Trichrome (x4) magnification, (a) Control external fixation.
Note woven bone formation within external callus, (b) Bisphosphonate external
fixation with rim of external callus and new woven bone formation, in contrast to (c)
Bisphosphonate plate fixation with little activity at the fracture site and no new bone




In the context of orthopaedic surgery a fracture is defined as a loss of continuity in
bone. Fractures occur due to excessive force in traumatic injuries or following the
application of a force consistent with normal activities on abnormal bone i.e.
pathological fractures or as the result of repeated sub-yield forces in normal bone i.e.
stress fractures.
The bone repair process during fracture healing is unique as it results in the
restoration of the same tissue i.e. bone rather than a scar1. Fracture healing is a
sequence of cellular events mediated by local factors that are influenced by the
mechanical and physiological environment. It is an energy dependent process that
1 3involves a combination of bone resorption and deposition " .
Fractures repair by two broad mechanisms. The mechanism of fracture repair that
predominates is dependent on the stability and gap size at the fracture site1.
Indirect Fracture Healing
The majority of fractures that are encountered in clinical practice are treated with
non-rigid modes of fixation. With non-rigid fixation, indirect fracture healing occurs
via bridging external callus with an intermediate phase of cartilage deposition. In this
mode of fracture healing there may be an initial period of macromotion prior to a
period of micromotion4'5 between the fragments before solid union occurs.
Ham and Harris6 in their textbook description of the histological appearance of
indirect fracture healing based on rabbit studies of healing rib fractures elucidated the
five stages of indirect fracture healing, namely;
1. Stage of haematoma ■
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There is activation of non-specific wound healing pathways that accompany
skeletal injuries. Haemorrhage from the bone ends lead to haematoma
formation that is contained by the surrounding soft tissues. Degranulating
platelets, macrophages and other inflammatory cells infiltrate the haematoma
to2;
i. prevent infection,
ii. secrete cytokines and growth factors,
iii. advance clotting into a fibrinous thrombus.
The rim of bone immediately adjacent to the fracture site is deprived of
blood supply and becomes ischaemic. Non-viable necrotic cells and other
debris are cleared by inflammatory cells2.
2. Stage of cellular proliferation
Cytokines and growth factors recruit additional inflammatory cells in a
positive feedback loop and also the migration of multipotent mesenchymal
stem cells that are responsible for bone formation and repair3. Mesenchymal
cells proliferate adjacent to the fracture site. A collar of active tissue, that
predominantly consist of chondrocytes and fibroblast, is formed that
surrounds each bone end and grows toward the other. Discrete cartilaginous
regions grow and merge to produce a fibrocartilaginous, semi-solid, splint
(soft callus) that provides early mechanical support to the fracture and will
later serve as a template for bony hard callus formation7. It had traditionally
been thought that osteoclasts were the key cell type for soft callus
replacement and hard callus remodelling. Currently, it is suggested that soft
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callus replacement is coordinated by multiple inflammatory cell types as part
of a non-specific catabolic process and is less dependent on osteoclasts than
the subsequent stage of bony hard callus remodelling2. This is supported by
the observation that in osteopetrotic mutant strains of rats with deficient
8 9 i
osteoclasts activity and mice with decreased osteoclast number , there was
no delay in the onset of hard callus formation and radiological union but a
greater callus volume at 6 weeks post fracture. There was only a persistence
of unmineralised cartilage in mice with near depletion or absence of
osteoclasts throughout the duration of fracture healing9. This suggests that
osteoclastic function is required but may not be the major factor for the
process of soft callus remodelling. Alternatively a group of proteins known as
matrix metalloproteinases (MMPs) that are secreted by a number of cell types
including bone, cartilage and vascular endothelial cells are believed to be
critical in soft callus remodelling. A decrease in MMPs has been shown to
impede soft callus removal leading to delayed fracture union10'". Colnot et
al" demonstrated persistence of unmineralised cartilage in closed stabilised
(external circular frame12) and non-stabilised13 fractures of the tibia in MMP-
9 deficient mice up to 21 days post fracture whereas mineralised hard callus
was established by day 14 post injury in wild-type mice controls.
Subsequently, in a similar study Behonick et al10 observed impaired soft
callus remodelling in MMP-13 deficient mice. MMPs also play a role in
driving angiogenesis as observed in studies of solid tumour proliferation14.
Angiogenesis is critical for the progression of fracture healing.
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3. Stage of callus
This stage is characterised by high levels of osteoblast activity. Angiogenesis
delivers osteoblasts along the semi-solid soft callus splint, initially at areas of
stability along the periphery, and enables the removal of fibrocartilage and
deposition of mineralised bone matrix2. The bone morphogenetic proteins
(BMPs) stimulate the differentiation of osteoblast from osteoprogenitor
cells15. Osteoblasts lay down new immature woven bone which forms the
hard callus that is visible on plain radiographs. This bridge of callus imparts
greater stability to the fracture. Of note, the osteoblasts secrete cytokines such
as, Macrophage-Colony Stimulating Factor (M-CSF)'6 and Receptor
Activator of NFkB Ligand (RANKL)17, that are essential for the recruitment
and function of osteoclasts that are present in increasingly greater numbers
during the latter stages of indirect fracture healing18.
4. Stage of Consolidation
The primary callus is transformed over time as a result of the orderly process
of woven bone resorption by osteoclast followed by the formation of lamellar
bone by osteoblast.
Bisphosphonates function primarily via osteoclast inhibition. Therefore,
observations on the effects of bisphosphonate therapy during indirect fracture
repair, provides information on relative osteoclastic activity within the stages
of indirect fracture repair. In one study where bisphosphonate was only
administered for two weeks pre-fracture19 and in another where a single dose
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of bisphosphonate only was administered at one week post fracture in a rat
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diaphyseal fracture model, stress at failure and radiological union was not
impaired at 6 weeks compared to controls. However, in experimental groups
where regular treatment was continued for a period in excess of 4 weeks,
which corresponds to the commencement of hard callus remodelling20, the
composition of woven to lamellar bone at the callus was greater at 4 months19
and up to 6 months20 compared to controls and rats that only received
bisphosphonate treatment up to one week post fracture. The inhibitory action
of bisphosphonate on osteoclast activity when administered during the period
of hard callus remodelling in the rat led to a delay in the remodelling of
woven bone to lamellar bone. This suggests that a high level of osteoclastic
activity is necessary for the remodelling of woven bone to lamellar bone.
5. Stage of remodelling
The bone is gradually strengthened along the lines of stress. The surplus
collar of woven bone is gradually resorbed. Osteoclastic resorption creates
erosive pits on the bone surface. New bone is then laid down in these pits by
osteoblasts2. Bisphosphonate treatment has been shown to decrease the
quantity of erosive pits21.
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Direct Fracture Healing
Direct healing occurs when the fractured ends of cortical bone are, rigidly held and
closely approximated with a degree of compression22"26. The term 'direct' is used to
denote the absence of an intermediate phase of connective tissue bridging the
fracture site1'3. Direct healing can be considered to be an extension of the
physiological repair and turnover of bone that is constantly occurring, whereby
micro-cracks are located and removed by osteoclasts. New bone is then laid down by
the ensuing osteoblasts following in the wake of the osteoclasts22.
Direct healing was first noticed following the internal fixation of fractures. The
earliest reported use of metalwork for internal fixation of fractures was by Carl
Hansmann in 1885. Sir William Arbuthnot Lane used the term, "as per primam
intentionem" to describe the radiographic appearance of absent callus in internally
fixed fractures. Robert Danis in 1949 noted the importance of compression and
stability at the fracture site to obtain direct healing, which he termed, "soudere
autogene". These principles profoundly influenced the AO (Arbeitsgemeinschaft fur
Osteosynthesefragen) Foundation that has since been responsible for the burgeoning
use of internal fixation to treat fractures with the goal of achieving early functional
recovery27.
The histological hallmark of direct healing is the osteonal remodelling unit
tunneling across a fracture site at points of cortical contact in the presence of
absolute stability23"25'28'29. This structure is known as a 'cutting-cone'. The head of
the 'cutting-cone' primarily contains osteoclasts that resorb the dense cortical bone
ahead as it travels toward and eventually crosses the fracture site. As the leading
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osteoclasts migrate forward it leaves a trail that is immediately filled by new vessel
ingrowth and osteoblasts that synthesise lamellar matrix on the pre-existing cortical
walls3 (Figure 1).
Figure 1: 'Cutting-cone', (a) Schematic diagram shows cutting cone advancing from left to right
led by multinucleated osteoclast which resorb bone followed by a central vessel and surface
osteoblast synthesising lamellar bone, (b) Photomicrograph of cutting cone passing through
rabbit cortical bone. From Shapiro F, European Cells and Materials 2008; 15: 53-76.
The existence of the 'cutting-cone' is dependent on the fracture stability and
ablation of the fracture gap achieved with close approximation of the fracture
fragments. Of crucial importance to the healing process is an adequate blood supply
to the fracture site.
Direct healing may also occur in the presence of stability and a minimal fracture
gap. In this so called 'gap-healing' primary bone formation occurs, bridging the
fracture gap, without an intermediate stage of connective tissue or fibrocartilage
formation1'23. This newly formed bone does not initially correspond to the structure
of the cortex. New bone is laid down by marrow derived vessels and mesenchymal
cells parallel to the fracture line. Remodelling then occurs by osteonal 'cutting cones'
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in the longitudinal weight bearing axis through the fragment ends across the newly
formed bone within the gap24"26'30.
The absence of woven bone formation and the immediate deposition of lamellar
bone has been reported to occur in rigidly stabilised fractures in dogs24'25. Following
rigid compression plating of transverse osteotomies in the dog radius Schenk and
Willenegger24 observed primary bone healing with 'cutting-cones' led by osteoclasts
traversing cortical bone adjacent to the plate and gap healing on the far cortex where
there was a fracture gap of 0.1mm. Olerud and Danckwardt-Lilliestrom" noted
similar findings following rigid compression plating of dog radii and in the less
vascularised dog tibia using the technique described by Schenk and Willenegger24.
Perren26 observed the same in rigidly plated sheep fractures with a fracture gap of
90 90
less than 0.1 mm. Direct fracture healing has also been observed in the rabbit ' .
Apart from the gap size the importance of stability has been stressed by several
authors 23"25'28'29. The need for stability is best described by the 'Strain' Theory26.
This states that, "a tissue cannot be produced under strain conditions which exceed
the elongation at rupture of the given tissue elements such as a cell". In the absence
of an intermediate cartilage phase the tissues that bridge the fracture fragments are
composed of bone that is relatively stiff. Therefore, minimal elongation of this small
gap is likely to lead to rupture of the endosteal woven bone bridging the fracture. The
tolerance to movement is least in small gaps as minimal motion causes a
proportionally greater degree of strain of the tissues fdling the gap.
Compression of the fracture fragments certainly contributes to the stability of
fracture fixation as it helps to eliminate inter-fragmentary strain. Perren et al have
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demonstrated that very small amounts of inter-fragmentary strain lead to bridging
external callus formation. Inter-fragmentary strain values of up to 2% enabled direct
fracture healing with no bridging external callus to occur in lamellar bone22. In
routine clinical practice, when rigid modes of fracture fixation are used, it is unlikely
that perfect anatomical reduction and abolition of the fracture gap is often achieved.
However, it is likely that the fracture fragments are approximated with a degree of
compression and the inter-fragmentary strain values within the existent gap is less
than 2% therefore allowing fracture healing to proceed with no external callus.
With direct healing techniques, patient functional recovery is accelerated as load
bearing though the injured bone can occur almost immediately following surgery.
However, immediate mobilisation following fracture reduction is not confined to
direct healing techniques and is also seen with non-rigid modes of fracture
stabilisation such as intramedullary nailing of long bone fractures. In these instances,
load is transmitted through the implant, therefore protecting the fracture reduction
until bone healing is complete.
Anatomical reduction of articular fractures is enabled with open reduction and
internal fixation hence avoiding abnormal areas of point contact at articular cartilage,
which may prevent premature joint degeneration31. For these reasons, due to the
enhanced functional recovery, and the predicted long term benefits of achieving
anatomical reduction particularly at the joint surface, operative fracture fixation has
become more common.
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Summary of Fracture Healing
There are considerable differences in the processes involved between the two bone
healing mechanisms. Osteoclasts are essential for the bone healing process, and their
activity is known to increase at the fracture repair site. With indirect fracture healing
via callus formation, osteoclastic activity peaks several weeks after the fracture18'32,
not during the early phase of fracture repair. In direct fracture repair, osteoclasts are
of pivotal importance for the progression of 'cutting-cones' and therefore, are critical
to initiate the process of direct fracture healing, Agents which impair osteoclast





Structure & Function of Bisphosphonates
Bisphosphonate therapy primarily targets osteoclast function. Therefore, prior to
describing the structure and function of bisphosphonates, a brief description is
provided of osteoclasts formation, activation and mechanism of action. Osteoclasts
are frequently a multinucleated cell, but may occasionally be mononucleated.
Osteoclasts are derived from the haematopoietic cell line. They originate from the
macrophage/monocyte lineage. Osteoclasts are formed from fusion of several
precursor cells from the colony-forming unit (CFU) which can give rise to both
granulocytes and macrophages. Multiple colony-stimulating factors (CSF)
synergistically promote osteoclast formation however, the presence of M-CSF is
essential. In mutations that lead to the absence of M-CSF production, osteopetrosis
results, characterised by a paucity of osteoclast that is reversible by the
administration of M-CSF33. The first visible step of bone remodelling is the focal
attraction of osteoclast to the quiescent bone. Hormonal mediation, bone damage and
cytokine release have been implicated in the stimulation of osteoclast activity34. The
precise mechanisms by which osteoclast recruitment and activation occur are not
fully understood.
The osteoclast is a highly energy dependent cell. It contains large numbers of
mitochondria and lysosomes. Osteoclasts mediated bone resorption occurs following
attachment of osteoclast to endosteal and periosteal surfaces creating a sealed off
environment. At sites of osteoclast attachment to the bone surface a ruffled border is
created by infolding of the osteoclast cell membrane. Within this sealed off area
lysosomal enzymes are secreted and a local acidic environment is created by
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operation of an ATP-driven proton pump. In this manner bone resorption occurs and
an erosion pit is created. With ongoing resorption the osteoclast effectively tunnel
their way in to mineralised bone. It is estimated that osteoclast may cut a depth of 20-
25pm/day in mineralised bone34'35. The lifespan of osteoclast is between 4-12 days.
Bisphosphonates are synthetic analogues of pyrophosphate, an endogenous
regulator of bone mineralisation. Bisphosphonates are comprised of two phosphonate
(P) groups linked by phosphoether bonds to a central carbon (C) atom. This P-C-P
structure is resistant to hydrolysis under acidic conditions and has a high affinity to
divalent metal ions, namely Ca2+, Mg2+, and Fe2+ that are abundant in bone36. This
enables targeting of bisphosphonate to bone mineral. There is an acidic environment
at sites of osteoclasts mediated bone resorption37 and bisphosphonates accumulate at
these sites as bisphosphonates have a reduced ability to chelate divalent ions at low
pH. The affinity of bisphosphonates to regions of low pH that correspond with sites
of osteoclast activity facilitates bisphosphonate inhibition of osteoclasts mediated
bone resorption. Bisphosphonates have been shown to be present in bone within 2
hours of administration38. In rat cortical bone, it accelerates osteoclast apoptosis and
this is evident as a decrease in osteoclast number within 24 hours of drug
administration39.
Bisphosphonates may be divided into two distinct classes based on the predominant
mechanism by which osteoclast mediated bone resorption is inhibited. The non-
nitrogen containing bisphosphonates such as clodronate and etidronate are
metabolised into non-hydrolysable analogues of adenosine triphosphate (ATP) that
accumulate within osteoclasts leading to osteoclasts apoptosis. The newer more
potent nitrogen-containing bisphosphonates such as ibandronate, risedronate,
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zolendronate and alendronate are not metabolised. They inhibit key enzymes within
the intracellular mevalonate pathway40. The mevalonate pathway is responsible for
the generation of sterols and isoprenoid lipids. These cholesterols and lipids are
important in osteoclast cell signalling. The isoprenoid lipids, in particular farnesyl
pyrophosphate and geranyl-geranyl pyrophosphate, are essential for the prenylation
and activation of small guanine transpherases (GTPases) such as Ras, Rho, Rac and
Cdc4240. A decrease of these agents impair36;
1. the formation of osteoclasts from osteoclast precursors
2. the recruitment and activation of osteoclasts
3. regulation of the osteoclast internal milieu.
This results in diminished osteoclast activity and may lead to osteoclast death by
apoptosis36'39. Currently, the main target protein of nitrogen containing
bisphosphonates is thought to be farnesyl diphosphate synthase (FDPS), a key
regulatory enzyme in the synthesis of isoprenoid lipids40. In vitro studies using the
J774 macrophage, which is frequently used as an osteoclast surrogate, have shown
that nitrogen containing bisphosphonates inhibit protein prenylation within these
cells and cause cell apoptosis41'42. However, addition of the isoprenoid lipids,
farnesyl pyrophosphate and geranyl-geranyl pyrophosphate suppressed the
bisphosphonate induced apoptosis in the J774 macrophage42.
Statins act on the intracellular mevalonate pathway via inhibition of the enzyme
HMG-CoA reductase. Laboratory studies suggest that statins enhance bone
formation. A meta-analysis of randomised clinical trials that involved data analysed
from more than 3000 patient did not however, demonstrated this class of drug to be
as efficacious as bisphosphonates for the reduction of fracture risk43. This is likely
35
due to the lower affinity of statins to bone in comparison to bisphosphonates and
therefore the effects of statins are less specific to bone.
GTPaies =£ RAS.RHOA.
RA<. (DC42, RABiA, RAP1A
Chart 1: The intracellular mevalonate pathway. HMGS1, HMG Co-A synthase; HMGCR,
HMG Co-A reductase, FDPS, farnesyl diphosphate synthase; FDFT1, squalene synthase;
GGPS, geranyl-geranyl pyrophosphate synthase; SQLE, squalene epoxydase. (Adapted from
Gong et al. Pharmacogenetics and Genomics 2011; 21: 50-53)
Nitrogen containing bisphosphonates are not metabolised and the proportion that is
not adhered to bone surface is excreted unchanged through the kidneys. Oral
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administration is recommended when fasting as food reduces the bioavailability of
oral nitrogen-containing bisphosphonates40. The pharmacokinetics of
bisphosphonates in humans is not fully understood. Bisphosphonate elimination is
difficult to estimate as a proportion of bisphosphonate that adheres to the skeletal
surface may be incorporated during new bone formation. A proportion of
bisphosphonate re-enters the circulation following its physicochemical release from
bone surface and following release during bone resorption. Therefore, the excretion
of bisphosphonate is related to renal function and the rate of bone remodelling and
turnover that in turn are affected by bisphosphonate activity. A prospective human
study assessed renal excretion of bisphosphonate in eleven women with established
post-menopausal osteoporosis for 18 months following intravenous administration of
30 mg alendronate given over four days. 50% of this was excreted in the urine within
the first five days and the rate of excretion decreased thereafter. At six months 67%
had been excreted and in the subsequent year only a further 3% was excreted.
Therefore at 18 months, 30% of the administered dose was likely to still remain
within the skeleton44. This skeletal retention may contribute to the prolonged
duration of bisphosphonate effect.
Bisphosphonate effects within bone are not merely confined to osteoclasts. During
the process of bone remodelling osteoclast activity is coupled to that of the
osteoblast. This allows for tight regulation of bone deposition and resorption.
Addition of osteoblast-like cells to osteoclast resorption pits in vitro are known to
enhance bone resorption. In vitro studies following pre-treatment of these osteoblast-
like cells with both nitrogen and non-nitrogen containing bisphosphonates before
addition to osteoclastic pits lead to impaired bone resorption21. It is suggested that
37
bisphosphonates stimulate the release of a substance from osteoblasts that in turn
inhibits osteoclasts mediated bone resorption45. Bisphosphonates have been shown
to enhance bone marrow stromal cell proliferation and differentiation in to osteoblast
in vitro46, however it remains unclear whether bisphosphonates have a direct in vivo
effect on proliferation of osteoblasts that results in enhanced bone formation47.
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Bisphosphonates in Clinical Practice
Bisphosphonates are an approved class of drug for the prevention of fragility
fractures48'49. Clinical evidence on the efficacy of bisphosphonates in fracture
prevention has been derived mainly from studies that demonstrate reduction in loss
of postmenopausal bone mineral density (BMD) and decreased fracture risk,
particularly in the vertebral column and femoral neck50. BMD measurements are a
predictor of fracture risk. A meta-analysis of 12 randomised, placebo-controlled
studies of antiresorptive drugs in postmenopausal women found that agents which
produce a larger increase in BMD have greater anti-fracture efficacy51. Low BMD
measurements are used to recommend antiresorptive therapies according to current
national guidelines48'49.
Prospective studies have shown that bisphosphonates prevent the loss of BMD52"54
and recent randomised, double blind placebo controlled studies even suggests an
actual increase in BMD55'56 with corresponding decreased incidence of fragility
fractures52"54'57 in postmenopausal women. This evidence has led to the introduction
of guidelines that recommend bisphosphonate therapy in patients with low BMD and
following a single fragility fracture48'49. Subsequently, there has been an explosion in
bisphosphonate uptake.
Currently, the United States Food and Drug Administration (FDA) have approved
four bisphosphonates, namely ibandronate, alendronate, risedronate, and
zolendranate for the treatment of postmenopausal osteoporosis. In placebo controlled
randomised studies ibandronate has demonstrated promising efficacy in reducing the
decrease in BMD and decreasing fragility fractures54"57. These results suggest that
ibandronate, when administered in a once monthly oral regime, may be more
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effective than other bisphosphonates as demonstrated by gains in lumbar spine and
hip BMD50. Furthermore, ibandronate has been shown to prevent fragility fractures
when administered orally using an intermittent dosing regimen54. Bisphosphonates
are associated with significant upper gastrointestinal symptoms and this may reduce
compliance. The convenience of an intermittent oral dosing regimen in addition to its
reported efficacy suggest that ibandronate may be a preferred bisphosphonate for
fracture prevention, hence its use in this study.
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The Effects of Bisphosphonates on Fracture Healing
Animal Studies
The effects of bisphosphonates on indirect fracture repair via callus formation has
19 20 32 58 67
been extensively studied in laboratory animals. Animal studies on rats ' ' ' " ,
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sheep and dogs ' have revealed no adverse effects of bisphosphonates, at doses
used to prevent post ovariectomy associated loss in bone mineral density (BMD), on
the restoration of mechanical integrity of healing fractures. The physical properties
of the healing fractures following bending, tensile or torsional stress are either
enhanced19'32'58'59'61'62'68'69 or remain unchanged20'64'66'67 in comparison to controls.
Generally, an increase in physical strength at the fracture site in bisphosphonate
treated animals was noted in conjunction with the observation of greater callus
volume on radiological assessment19"32'58'59'61"63'65'67'68'70. However bisphosphonate
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therapy in beagle dogs and rats ' respectively had no effect on bending strength
of mid-shaft diaphyseal fractures despite the larger callus width noted on plain
radiographs. This suggests that the callus formed following bisphosphonate therapy
may have impaired physical properties but strength at the fracture site is
compensated for by the structural properties that are provided by a bulkier callus
volume.
The callus composition in bisphosphonate treated animals appears to have a lower
mineral content65 and a greater proportion of woven to lamellar bone19'20'32'59,
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suggesting a delay to the process of callus remodelling ' ' ' ' in indirect fracture
healing. There appears to be a dose dependent effect on callus remodelling with
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higher doses of bisphosphonates having a greater effect on decreasing callus
mineralisation69.
The timing of bisphosphonate therapy relative to the fracture process affects bone
repair. In a rat femoral fracture model, bisphosphonate administration up to one week
post fracture did not affect radiological union or failure stress at six weeks19'20.
However, in groups where regular bisphosphonate treatment was continued for
longer periods post-fracture, i.e during the commencement of hard callus
remodelling1'20, there was a greater proportion of woven to lamellar bone within the
callus at four months19 and up to six months20 compared to healthy controls and rats
that only received bisphosphonates up to the first week of fracture healing.
The callus characteristics and rate of remodelling are related to the bisphosphonate
concentration and the bisphosphonate inhibitory effect on osteoclasts within the
healing bone. High doses of bisphosphonate have been shown to adversely affect the
mechanical strength of healing fractures in dogs69.
It is known that there is heightened osteoclast activity at sites of bone repair. A
recent study using a sheep tibial osteotomy stabilised with an external fixator showed
that the osteoclast numbers at the fracture site gradually increased during the
duration of indirect fracture healing with a sharp rise after three weeks18, that may
indicate osteoclasts importance in the callus remodelling phase that begins between
the third and fourth week post fracture1'20.
Following administration of a single dose of zolendronic acid to healing rat femoral
fractures, Amanat et al32 found larger callus volumes, and increased mechanical
strength in torsion at the fracture site with evidence of delayed remodelling when the
single dose was delivered at one and two weeks post fracture compared to at the time
42
of fracture. A greater effect was noted in the two weeks post fracture group.
Furthermore, the concentration of zolendronic acid was greatest within the callus of
the delayed treatment group due to the high affinity of bisphosphonates to areas of
osteoclast activity which would have been greater at this time point.
As mechanical integrity is critical to functional recovery and rehabilitation post
fracture, delaying the onset of bisphosphonate therapy following fragility fractures
may be clinically beneficial. The longer term effects of this delayed callus
remodelling remains uncertain but studies of healing fractures in sheep up to 3
months68, dogs to 5 months69 and rats up to 12 months62 show no adverse effect on
mechanical strength.
A recent study by Bauss et al72assessed the healing of drill holes in beagle dog
tibiae following administration of systemic ibandronate therapy. Ibandronate
administration did not adversely affect the amount of newly formed bone within the
defects. It was however, assessed in the presence of ipsilateral femoral marrow
ablation. Bone marrow ablation has been shown to enhance osteogenesis at distant
sites and this may have had a confounding effect on the results. In a study using aged
rats there was a significantly greater thickness in the zone of provisional
calcification, the site at which osteoblastic bone formation occurs, of the mandibular
condyles within 6 days following tibial marrow ablation through a drill hole in
comparison to controls where a tibial drill hole only was made without marrow
ablation73. Furthermore, drill hole defects do not replicate the clinical scenario of
primary fracture repair.
Contrastingly, in a rabbit calvarial defect model pamidronate therapy was observed
to impair angiogenesis and resulted in a greater proportion of fibrous tissue to bone
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formation within the defect at 8 weeks74. This suggests that via an inhibitory action
on angiogenesis bisphosphonates may impair primary bone formation.
Human Trials
There have been two prospective randomised double-blinded, placebo controlled
clinical studies that assessed the bone mineral density (BMD) in the region of healing
distal radius fractures treated non-operatively75'76. Both studies investigated post¬
menopausal women that were commenced on alendronate76 and clodronate75
respectively following fracture and followed up to 12 months. The clinical and
radiographic assessment of fracture union was not affected in both studies. The
authors concluded that the bone mineral density was greater in the bisphosphonate
treated groups at the fracture site, thereby suggesting that bisphosphonate therapy
prevents the loss in bone mineral density associated with fractures. However,
impaction of the fragments, as frequently occurs in wrist fractures may have led to
increased BMD measurements locally in the region of the healing wrist fractures and
therefore confounded their findings. Furthermore, as no measurements were made of
the callus size the rise in BMD could be related to a larger callus bulk as previously
demonstrated in animal models of indirect fracture healing with bisphosphonate
treatment.
The longer term effects of bisphosphonate therapy especially on cortical bone,
requires further study. This is especially relevant in light of emerging clinical reports
of low energy diaphyseal fractures77"79 and subsequent delayed healing78 as observed
on radiographs in patients on long term continuous alendronate therapy of between
three to eight years.
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Summary of Bisphosphonate Effects on Fracture Healing
A number of studies have reported that during indirect fracture healing,
bisphosphonate therapy delays callus remodelling and prevents fracture associated
decrease in bone mineral density. The delay in callus remodelling results in a callus
of poorer mechanical property but this is associated with a larger callus volume that
compensates for the strength at the fracture site.
As direct fracture healing proceeds through different biological processes it is not
possible to extrapolate from previous research, that either used non-rigid stabilisation
or bone defect models, the effect of bisphosphonate therapy on direct fracture
healing. As osteoclasts are of pivotal importance for the initiation of the progression
of osteonal remodelling units that are essential at the onset of direct fracture healing,
bisphosphonates may have a detrimental effect on direct fracture repair.
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Bisphosphonate Effects on Bone Remodelling
The promising effectiveness of bisphosphonates in fragility fracture prevention
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occurs at the expense of decreased bone remodelling ' " . In a one year placebo-
controlled study using adult beagle dogs, comparing two nitrogen-containing
bisphosphonates at six times the recommended therapeutic dose, Li et al.71 reported
more 'microcracks' and a reduced association between 'microcracks' and osteoclasts
resorption sites in bisphosphonate treated dogs. The impaired bone remodelling,
resulted in microdamage accumulation. One year of alendronate therapy, at the
treatment dose shown to reduce the incidence of fragility fractures, in a placebo
controlled human study revealed decreased plasma biochemical markers of bone
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turnover , which may be a reflection of reduced bone remodelling. In dogs
microdamage accumulation at 3 years following alendronate therapy was not
significantly different to that observed following one year of similar therapy,
however the bone strength following adjustment for BMD was reduced in the
alendronate treatment group compared to controls82. Recent clinical evidence has
emerged that suggests an association between low energy diaphyseal fractures and
long term nitrogen-containing bisphosphonate therapy77"79. Bone biopsies revealed
severely reduced surface osteoblast and low surface osteoclast numbers with
suppressed new bone formation78. This suggested that long term bisphosphonate
therapy impaired the recruitment of both osteoblast and osteoclast to the site of bone
damage. This may lead to accumulation of microdamage and subsequent crack
propagation leading to fracture.
Direct fracture healing that predominates in plate fixation can be considered an
extension of the normal physiological processes involved in bone turnover and
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remodelling, where bone microdamage is identified and repaired. The growing
evidence that bisphosphonates inhibit bone remodelling support the hypothesis that
bisphosphonates may have a detrimental effect on the process of direct fracture
healing.
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Bisphosphonate Effects on Cortical Bone
Animal trials in rodents, canines and primates have consistently shown that
bisphosphonate increases the compressive load at failure of cancellous bone within
the vertebra83"88 and femoral neck83'84. Prospective human studies50'52"54 show that
bisphosphonates prevent loss of BMD and decrease fracture risk particularly in the
vertebral column and femoral neck with recent randomised, double blind placebo
controlled clinical studies55'56 even suggesting an actual increase in BMD with once
monthly oral bisphosphonate.
However, studies that demonstrate an increase in cancellous bone compressive
strength and preservation of BMD with bisphosphonate therapy have not shown
consistent effects on diaphyseal bending strength83'89. The effect of bisphosphonates
on cortical bone mechanical properties, particularly of the uninjured contra-lateral
cortical bone remains poorly reported.
This is of particular importance as cortical bone remodels less quickly than
cancellous bone and bisphosphonate inhibition of remodelling may lead to
accumulation of 'microdamage'71 that may manifest clinically as cortical
insufficiency fractures77"79.
Following a fracture a decrease in bone mineral density occurs both within the
injured limb76 and in the contra-lateral uninjured limb90. The effect of
bisphosphonate administration during the fracture healing process on the radiological
density and mechanical properties of the uninjured diaphyseal bone in the contra¬




Animal fracture models have been extensively used in pre-clinical studies of
fracture healing. The choice of animal used is mainly influenced by the following:
1. Intervention to fracture repair being assessed e.g.
a) method of fracture stabilisation
b) systemic or local pharmacological agents (e.g. bisphosphonates, bone
morphogenetic proteins, synthetic bone graft)
c) systemic or local disorders that may influence bone repair (e.g. osteoporosis,
diabetes mellitus, immunodeficiency, limb paresis)
d) exogenous agents (e.g. ultrasound therapy, electrical stimulation)




3. Similarity of animal model to clinical environment
4. Animal handling cost
5. Availability of genetically modified models, e.g. knockout mice
6. Societal acceptance of a particular animal species being used for research
Animal models to study fracture repair have been described in; small animals such
as mice12'13'91"95, rats96"103 and rabbits6'23'29'30'104; domestic animals such as cats'05 and
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dogs ' ; larger animals such as sheep" ' and horse ; and in non-human
primates109'110.
In general, small animal models, especially in the mice, have been used to study the
molecular aspects of fracture repair. Understanding of the mouse genome has
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enabled fracture studies to be performed on genetically modified strains that display
phenotypic traits of a particular disorder. The low cost of purchase and upkeep for
mice in addition to the substantial understanding of the mouse genome make it an
increasingly common choice for fracture healing studies11 12. Surgical stabilisation
of fractures in small animals is technically demanding and biomechanical testing of
113 •small bone specimens is difficult . Experiments that investigate the mechanical
properties of surgical stabilisation devices for fracture repair and that have a focus on
assessing the biomechanical environment of fracture repair frequently use larger
animal models. The classical descriptions of direct fracture repair were based on
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rigid plating of osteotomies in the dog" ' and sheep" . Direct fracture healing has
• • 23also been observed following rigid plating of tibial osteotomies in the rabbit" .
The properties of bone and its response to loading and fracture have differences
between animal species. It is believed that the closer a species is on the phylogenetic
scale the similarities would be greater112. Animal models are essential for the study
of fracture healing. However, the observations made in one animal species may not
be identical to that seen in another species or in human studies.
It is often stated that bone remodelling does not occur in the rat111112. However,
Bentolila et al"4 axially loaded the right ulna in sixteen adult rats, then ten days later
loaded the contra-lateral ulna prior to immediate sacrifice. They observed that the
right, earlier loaded, ulna diaphysis had 40% less 'microcracks' than the contra¬
lateral ulna diaphysis that was loaded immediately prior to sacrifice. On confocal
microscopy of fuchsin stained bone sections there was cortical remodelling
near'microcracks' and intracortical resorption associated with osteoclastic tunnelling.
This suggests that the 'microcracks' are being repaired by a process of bone
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remodelling. This observation led us to suspect that direct fracture healing may occur
in the rat provided that there is anatomical fracture reduction and a biomechanical
environment of absolute stability to permit progression of 'cutting cones' across the
fracture site. A rodent model of direct fracture healing has not been previously
described.
In the following section a summary of frequently used small animal models of
fracture healing is presented.
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Small Animal Fracture Models
Mouse Fracture Models
Its small size renders surgical procedures to be difficult. Closed tibial diaphyseal
fracture models have been described using variations of a guillotine device12'13'91.
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Bourque et al reported in a closed tibial fracture model with no immobilisation that
fractures healed with endochondral ossification within 21 days. Hiltunen et al91
inserted 0.2mm stainless steel rods into the tibial intramedullary canal bilaterally in
68 mice prior to creation of a closed fracture. Nine animals died during the
perioperative period and one developed an infection. Malposition of the
intramedullary rod was reported in only one of the remaining 116 fractures. Fractures
healed by endochondral ossification with visible external callus on radiographs.
Thompson et al12 described a model of fracture healing via intramembranous
ossification in the mouse tibia following external fixation of a closed tibial fracture
with a circular frame. The frame consisted of two aluminium rings stabilized by
threaded rods secured to the proximal and distal tibial metaphyses with smooth cross
pins. This produced a more stable construct and prevented rotation of the fracture
ends when compared to an intramedullary rod. A small amount of cartilage was
detected on immunohistochemistry by detection of CoIIIa, a marker of
chondrogenesis, at two weeks, but not at earlier time points at days 4 and 7, in four
of ten animals. At three weeks there was woven bone bridging the fracture site with
external callus on radiographs. The cartilage noted may be due to instability of the
frame construct by three weeks either due to loosening at the interface between the
smooth pin and metaphyseal bone or the aluminium ring. In the three models
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described above, where closed fractures were created with a guillotine device, there
was no mechanism to prevent an associated fibula fracture (1/3 of animals reported
12
by Thompson et al ).
There are two described models of murine femoral osteotomies stabilized with
uniaxial fixators whereby healing occurred by endochondral ossification93'94. In the
model by Connolly et al93 a drilling jig with a greater distance between the proximal
and distal holes was used to permit compression of the fracture on external fixator
bar application. In this study animals were individually housed in cages fitted with an
infra-red beam motion detection system. They observed, animals that were more
active had larger external callus.
Recently, Histing et al92 described a mouse femoral osteotomy model stabilized
with a locking plate whereby fracture healing progressed via intramembranous
ossification. A transverse femoral osteotomy was made with a 0.22mm diameter
Gigly saw. A 4-hole 1.5 mm thick titanium plate was used. In 4 (20%) of 20 animals
there was intra-operative failure of plate fixation. At two weeks, eight animals were
sacrificed. On trichrome staining they observed callus of woven bone with no
cartilage. At five weeks there was radiological union and on histology there was
woven bone bridging the fracture in all of the eight remaining animals. Cutting cones
were not observed to traverse the osteotomy site in this model
A cortical drill hole model in the mouse tibia has been reported95. Within one week
of a 0.5mm tibial drill hole woven bone was observed in the defect with some
periosteal cartilage at the periphery of the defect. New woven bone filled the marrow
cavity defect by four weeks post injury.
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Rat Fracture Models
The closed rat femoral fracture model by a guillotine device following
intramedullary retrograde reaming with a 20 gauge needle and femoral stabilisation
with a 0.45 mm diameter Steinmann pin was originally described by Bonnarens and
Einhorn97 in 1984. It has been widely used for fracture healing studies in the rat
femur and subsequently adapted for use in the tibia of rats98 and mice91. Bonnarens
and Einhorn97 observed that in 38 of 40 animals there was a transverse fracture in the
middle third of the femur diaphysis. In a further two the fracture in the femur
diaphysis was of a transverse oblique pattern. Therefore the guillotine device was
able to reproduce a standardised closed fracture. However this device when used in
the tibia often created a concomitant fibula fracture but was able to reproduce a
go
standardized rat tibial diaphyseal transverse fracture in 159 of 176 animals .
Bak et al115 produced a closed tibial diaphyseal fracture following application of a
3-point bend with a specially designed forceps. A smooth intramedullary K-wire was
then introduced across the fracture. The aim of this study was to assess the effect of
the fracture level on the mechanical properties of the healing fracture. The failure
load and stress decreased with more distal fractures. The authors concluded that this
was likely related to less support provided by a correspondingly more distal fibula
fracture that will not be embedded in muscle distally in the leg and also due to the
shorter working length of the intramedullary K-wire across the fracture site in lower
tibial fractures. This study emphasised the importance of fracture standardisation.
Rat femoral osteotomy models stabilized by an intramedullary pin101 and with an
external fixator103 have also been described. Russell et al96 described femoral plating
with a 1 mm thick stainless steel plate in the rat femur followed by osteotomy of a 5
56
mm segment of bone to create a critical size defect segmental non-union model with
rigid fixation.
Rabbit Fracture Models
Rahn et al23 reported direct fracture healing following rigid stainless steel dynamic
compression (DC) plating of eight adult rabbit tibial osteotomies. The site of
osteotomy in the tibial diaphysis was stripped of periosteum, for a length of greater
than twice the diameter of bone at the osteotomy site, prior to sawing with a handsaw
of 0.1mm thickness under constant cool saline irrigation. A 6-hole plate was used. In
three of eight animals the screws holding the plate had loosened. The ensuing
instability resulted in resorption of the fragment ends and development of
interfragmentary cartilage with bridging callus. In five animals with rigid fixation,
'cutting-cones' were seen to traverse the osteotomy site on the surface beneath the
plate with no evidence of interfragmentary resorption (i.e. contact healing). In the
cortex opposite to the plate where a small gap occurred, new bone formed parallel to
the osteotomy line with 'cutting-cones' crossing the gap perpendicular to the
osteotomy site (gap healing). This histological appearance is similar to that reported
in the dog25'106'116 and sheep28. The observations of Rahn et al23 were reproduced by
Ashhurst et al29 in 24 of 29 similarly DC-plated rabbit tibia. In four animals there
were fractures around screw holes resulting in instability and one animal died under
anaesthesia. However, when the fragments were approximated, within 0.5mm to
1.0mm, and stabilized with a less stiff plastic plate indirect fracture healing occurred
with external callus.
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Brighton et al104 used a transverse midshaft fibula osteotomy to assess the effect of
capacitively coupled electrical fields on fracture repair. No fixation or external
immobilisation was used as the fibula is synostotic to the distal tibia. Fracture repair
occurred with intermediate cartilage formation and bridging callus on histology.
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Choice of Animal Fracture Model
Rigid plate fixation in the mice is difficult due to the small size of bone. A model of
locking plate stabilisation in the mouse femur did not produce absolute stability to
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permit direct fracture healing . Haversian remodelling is known to occur in the
rat1 '4. It was therefore reasoned that direct fracture healing was likely to be observed
in the rat under suitable conditions. Based on this the rat was chosen as the animal
model for this research. Furthermore, the animal cost for purchase and handling of
rats is at least three times less than that for a larger animal such as the rabbit at the
University of Edinburgh animal research facilities.
The tibia was preferred to the femur as surgical approach was more direct and
positioning for serial x-rays to assess the progression of fracture healing would allow
greater standardisation. As a surgical approach would be required for plate fixation
an osteotomy model was used as this allowed for standardisation of the 'fracture' and
avoided a concomitant fibula fracture which may impair the mechanical properties of





Both functional and imaging techniques were used to assess fracture healing.
Mechanical Testing
Bending stress has been widely used in previous studies to assess the mechanical
properties of healing fractures in rodents19'59'62'64'119 and therefore the results
gathered from this research would be comparable to evidence in the published
literature. Bending causes tensile stresses on the convex surface and compressive
stresses at the concave surface. 3-point bending tests have been used by several
authors to assess the mechanical properties of healing fractures in the rat67'99'120'121.
This is likely due to the ease of testing especially in small bone specimens.
A four-point bend is superior to a three-point bend as it produces pure bending
between the two middle loading points and ensures that transverse shear forces,
which are not measured, are eliminated'l3'122. This produces a more accurate
measurement of the failure load and has previously been used to measure the failure
load of healing mouse tibial fractures91.
Alternatively, testing bone mechanical properties with pure tensile force can yield
highly accurate measurements, but this method of testing requires relatively large
specimens that are able to be shaped to create a design where the majority of strain
will occur in the mid-portion of the specimen during the application of a uniaxial
tensile force113. Hence, this method was not suitable for use in small rodent bones.
Testing in pure compression is particularly useful for testing small specimens. It was
less accurate due to end effects on the bone during testing that was most marked in
smaller specimens"3.
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Several authors have used testing in torsion118123 to report on mechanical properties
of healing fractures in rodent bone. However, testing in torsion produces tensile
stress in addition to shear stresses that were difficult to quantify accurately124. Pure
shear test of bone requires bone of specific shape and size that would be difficult to
obtain from rodent bone113.
Four-point bending stress was used as it bears resemblance to the mechanics of
tibial fractures seen in clinical practice and the material properties can be accurately
measured by using the "Elastic Beam Bending Theory" as will be described later.
Specimens require adequate storage and preparation to enable accurate mechanical
testing. Tissue autolysis of bone is known to begin early following specimen
retrieval125. As this may have affected the mechanical properties of bone, it was vital
that specimens were adequately stored to prevent this process. It has been shown that
freezing specimens at -20°C in isotonic saline solution for 3-4 weeks prior to bending
test does not affect the strength of human cortical bone when compared to controls
tested in similar conditions immediately following retrieval126. This method of
storage by freezing in saline, prior to mechanical testing has been widely used in
previous experiments to assess the effects of bisphosphonates on fracture healing in
rodents32'58'61'64'119 and was therefore used in this thesis.
The mechanical properties of bone are affected by temperature and moisture113. At
temperatures below 27°C bone fails at a lower stress and at warmer temperatures
there is a larger degree of plastic deformation prior to failure that results in an
apparent greater stress at fracture1"7. Bone when dehydrated behaves in a more
i 113brittle manner . Therefore mechanical testing of specimens were performed whilst
the bone was still hydrated and warm. This was to maintain bone hydration and
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Radiography
Serial Radiographs
This is a simple method to monitor the progression of fracture healing. The process
of direct fracture healing was first considered following observations of fracture
repair without external callus on serial radiographs27. Clinicians routinely monitor
fracture healing with serial radiographs. Fracture alignment, visibility, callus
formation and fixation are qualitatively assessed.
Callus Index
Callus index in healing tibial diaphyseal fractures is defined as the ratio of the
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maximum callus diameter to bone diameter at the similar level as the callus
(Figure 21). The callus size increases until stability is achieved across the fracture
site prior to commencement of callus remodelling6.
The influence of callus size on fracture healing strength was noted by Lindsay and
Howes129 in a rat study of standardised fibula fractures without immobilisation. They
noted that there was a peak in load at failure of healing fractures at day-21 that
corresponded with the peak in callus size. After day-21 there was a period of decline
in the failure load of healing fractures and also a decrease in callus size prior to a
secondary rise in strength at the fracture between day-33 and day-45 as the callus
size continued to decrease to its pre-fracture bone diameter. These radiological
observations of callus size are in agreement with subsequent histological studies of
healing rat fractures whereby the callus size is noted to decrease and remodel
between the third to fourth week post fracture20. Within the clinical environment,
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this similar observation has been noted in a prospective clinical study of seven
patients with non-comminuted tibial fractures treated with uniaxial external fixators.
Gardner et al5 observed that the callus index increased in relation to an increase in
stability at the fracture site.
Eastaugh-Waring et al128 in a retrospective study of three groups of 15 patients each
with tibial fractures that were treated with cast immobilisation, intramedullary nail
fixation or external fixation observed a sharp rise in callus index in the early weeks
post fracture, with a flattening of the curve prior to reaching a peak callus index and
a subsequent decrease in all three groups. The peak in callus index occurred shortly
after cast and external fixator removal suggesting that monitoring this radiographic
measure may indicate progression of fracture stability and help advise patients on
returning to function.
It has been suggested that serial callus index measurements in non-rigidly stabilised
19c
healing tibial fractures peak at a point that coincides with callus remodelling ~ .
Therefore serial callus index measurements enabled assessment of the initiation of
callus remodelling and progression to fracture consolidation.
Visibility of Fracture Line
This method has been used in the assessment of experimental fracture healing in the
rat61. In a study to assess the dosing effects of a systemic agent on closed tibial
fractures in 40 adult goats stabilised with external fixators, weekly standardised
radiographs were obtained up to the point of animal sacrifice. Soft tissues were
dissected prior to contact radiographs and mechanical testing. All radiographs were
reported by two independent radiologists who were blinded to the treatment that the
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animals received and the time point from fracture that radiographs were taken. The
visibility of the fracture line was scored on a 3-point scale as either; absent, partially
disappeared or visible. The findings were that this method of assessing fracture line




This allows for assessment of the general morphology at the fracture site. In order
to obtain sections of bone with optimum preservation of cellular architecture samples
are fixed in formalin, decalcified and embedded in paraffin.
Formalin is routinely used for tissue fixation as it preserves tissue morphology with
few artefacts, is cheap, easy to prepare and is used widely131. Formalin fixation
involves the development of protein cross-linking and the formation of co-ordinate
bonds for calcium. Forty-eight hours is accepted as sufficient for tissue fixation as
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the quantity of tissue fixation plateaus after this period ' . Delayed
commencement of fixation (>30min) results in increased proteolytic degradation and
prolonged fixation (>48hrs) results in excessive protein cross-linking which alters the
131
protein structure and may adversely affect the quality of specimen staining .
Bone requires decalcification prior to embedding in paraffin to permit sectioning.
Removal of calcium and resulting dissolution of hydroxyapatite can be achieved by
strong acids or chelating agents. Acids such as nitric, hydrochloric and formic acid
achieve rapid decalcification at the expense of hydrolysis of nucleic acids and
denaturing enzymes but may hinder subsequent assays and immunohistochemical
techniques133. Therefore bone specimens are decalcified in a chelating agent,
disodium ethylenediamine tetraacetic acid (EDTA). Decalcification of bone with
EDTA as initially described by Nikiforuk134 is still regarded as the most suitable
1 0-3









1. A model of direct fracture repair can be developed in the rat.
2. Bisphosphonates inhibit the process of direct fracture healing (as this is 'led' by
osteoclasts) but not that of indirect healing.
Research Question:
Does ibandronate (a nitrogen containing bisphosphonate) therapy inhibit direct
fracture repair in the rat?
Specific Aims
To investigate the effect of a systemically administered bisphosphonate on the
process of direct and indirect fracture healing in diaphyseal fractures stabilised
rigidly using plate fixation or non-rigidly with an external fixator using clinically
relevant fracture models.
Null Hypothesis: Ibandronate has no affect on fracture healing in-vivo
Clinical Relevance:
The results of this study will guide the orthopaedic surgeon in their choice of
fracture fixation technique for the management of the growing number of
osteoporotic fractures in patients already on bisphosphonate therapy. The findings
will be of particular relevance, to advise whether orthopaedic surgeons should use





All animal procedures adhered to the Animals (Scientific Procedures) Act 1986 and
were approved by the appropriate local and national authorities. Animals were fed
standard rat chow and provided with water ad libitum. Animals were housed in
individual cages at constant temperature (21 ± 1°C) and humidity (45% - 55%) using
a 12 hour light/dark cycle. Surgical procedures were only commenced after one week
of housing to allow for acclimatisation to their new environment. Techniques and
implants were initially trialled in rat cadavers prior to application in experimental
animals.
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Rat Model of Direct Fracture Healing
The model of tibial plating used in this study was developed with reference to a
model of plating rat femoral shaft osteotomies96. This previously described technique
was used to obtain rigid internal fixation at the fracture site, thus enabling healing
without callus. However, it was designed as a model of femoral non-union with an
osteotomy gap of 5mm in order to evaluate compounds that will enhance primary
bone formation while eliminating the effects of callus formation. Therefore,
adaptation was required to develop a model of direct fracture repair, similar to that
seen in clinical practice when open reduction and internal fixation is achieved by
using compression plate fixation.
The tibia was chosen as it had a suitable flat surface medially which enabled
positioning of a plate on to bone. The use of two screw holes on either side of the
fracture site was maintained, as this was the minimum number of fixation points
required to obtain rigid stability in all planes.
Essential to this model of fixation was the development of the following materials:
• Hardware for internal fixation
• Jig for positioning of screw holes to ensure apposition at fracture site on plate
application
• Cutting device for osteotomy
Based on repeated measurements of 22 extricated tibia from eleven adult male
Sprague-Dawley cadavers with a mean (+SD) weight of 496 (±46.1)g, the average
tibial dimensions were as follows:
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Table 1: Mean (+SD) tibial dimensions from cadaver rat tibia
These values correspond with adult rat tibial dimensions as previously
observed121'135.
1.6 mm diameter threaded screws were chosen as these were readily available in the
4mm length required. A screw of 1.6 mm diameter would still leave just under 50%
of the sagittal bone width intact at the narrowest point should the plate be inserted
distally on the tibia. A 4 mm length was required to ensure there was purchase on the
lateral far cortex during screw insertion especially with the proximal screws, as the
tibia is thicker in the coronal plane proximally. The plate thickness was chosen at
1mm as per described in the femoral plating model96. The initial plates were made to
a length of 16 mm and width of 4 mm to accommodate four 1.6 mm screw holes. All
metal-ware was stainless steel due to its favourable combination of mechanical
properties, biocompatibility, corrosion resistance and cost effectiveness.136 These
properties allowed provision of adequate rigidity to achieve absolute stability at the
fracture site and prevented adverse antigenic reactions.
A trimmed junior hacksaw blade with a width of 0.5 mm (RS Components, UK)
was chosen to create the osteotomy. This was to reduce thermal necrosis of bone that
may be produced by the use of high speed oscillating saws in the absence of
irrigation137. A 1.25 mm drill bit powered by a hand held Dremel® Multitool was
used to make 4 screw holes in the bone. A custom made 4-hole jig was used as a
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guide to drill the bone. The spacing between the 2nd and 3rd hole on the jig was 0.5
mm greater than the space between the corresponding holes on the plate. This was to
ensure apposition at the osteotomy site during plate fixation. The jig had a
roughened inferior surface to prevent sliding on the bone surface and holes on the
lateral surface to thread a fine wire to secure the jig to bone during drilling. The jig
height was 4mm and the four-holes were of 1.25mm diameter to ensure a tight fit
with the drill bit to obtain accurate positioning and alignment of the drill holes. Once
4-holes were drilled in bone and tapped with a Ml .6 fluted tap, the osteotomy was
created with the previously mentioned saw blade. The plate was then applied and
secured with 4 fully threaded 1.6mm screws. Tightening of the screws caused
apposition at the fracture site (Figure 2).
Figure 2: (a) Transverse osteotomy in pre-drilled bone and (b) apposition at osteotomy site
Following successful application on ten rat cadaver tibiae, this plate was used to fix
tibial osteotomies, initially in two adult Sprague-Dawley rats. The osteotomies were
created at the proximal diaphysis of the tibia to allow the placement of 4 screws in
areas where the tibia remains wide. Unfortunately, as the proximal screws were in
metaphyseal bone, they loosened and the construct did not provide rigid fixation as
demonstrated in the x-ray (Figure 3) below that shows proximal screw loosening.
Histology confirmed external callus formation and cortical translation with a visible
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osteotomy gap. Therefore, in subsequent procedures the plate was placed more
distally on the tibia to ensure that all four screws were placed in cortical bone.
Figure 3: Plain radiograph of pilot study at 5 weeks post fracture shows proximal screw
loosening and callus formation
Furthermore, the integrity of the fibula may have impeded compression at the
osteotomy site despite its contribution to stability. As previous research on fracture
healing revealed that stress at failure in 3-point bending117 and torsion118 of healing
tibial fractures were reduced in the absence of an intact fibula, the fibula integrity
was preserved. Therefore, a narrower osteotomy had to be created, that could be
compressed during plate fixation, and that remained in compression despite the effect
of the intact fibula in preserving tibial length. Hence, a fine circular disc saw with a
thickness of 0.1 mm (RS Components, UK, Kit no: 543-967) was used in
conjunction with saline cooling. This circular disc saw was powered by a hand held
Dremel® Multitool.
This modification in conjunction with a refined jig to accommodate the 0.1mm
circular saw, achieved the desired compression at the osteotomy site in five cadaver
tibia whilst the fibula integrity was preserved. This was then trialled in two rats.
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However, between 1 -2 weeks post fracture the tibiae had re-fractured through the
most distal screw (Figure 4). It was considered that this was most likely related to
i oo
stress concentration due to the relatively large screw diameter to bone size ratio .
Figure 4: Fracture through the 4lh screw hole on the narrower area of the tibia distally
when 1.4mm screws used.
Subsequently the screw diameter was reduced to 1.2mm. The plates were reduced
in length and width, and the screw hole diameter reduced correspondingly. The
plates were sized at 12mm x 3mm x 1mm. The dimensions for the screw holes on the
jig had to be reduced accordingly. With these changes there were no further peri-
prosthetic fractures. On plain radiographs, there was no evidence of external callus
(Figure 5).
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Figure 5: Radiograph 6 weeks post fixation with 12mm x 3mm x 1mm plate revealed no
external callus
Figure 6: H&E stained coronal section at x5 magnification of tibia fixed with 1mm thick
plate. Note cortical gap on upper surface. This area is opposite the surface of plate
application
However, histological analysis of coronal sections revealed a small gap at the bone
cortex on the far side away from the surface at which the plate was applied (Figure
6). In order to avoid this asymmetrical compression at the fracture site, the plates
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required pre-bending to provide more even compression at the osteotomy during
screw tightening. In order to permit pre-bending and plate conformation during
screw tightening, the plate thickness had to be reduced whilst still maintaining an
83
adequate amount of stiffness. Trial plates of 0.8mm, 0.6mm and 0.4mm thickness
were used to fix osteotomies in cadaver rat tibia. Taking into account the feasibility
of manually bending the plate during surgery and the ability of the plate to conform
to the tibial surface, a thickness of 0.4mm was chosen. The thicker plates were
difficult to pre-bend and occasionally either displaced the fracture or cracked the
bone during screw tightening when attempting to conform the plate to the tibial
surface.
(a) (b) (c)
Figure 7: (a) A-P radiograph of plated tibia, (b) Valgus stress. (c)Varus stress. Note no widening
or translation of osteotomy on stress application.
Subsequently the plate dimensions used for fixation of rat tibial osteotomies were
12 mm x 3 mm x 0.4 mm. Manual stress testing of this construct in 15 cadaver rat
tibia revealed no macroscopic evidence of mobility at the fracture site on application
of bending forces. This plate was then initially trialled in four animals. Immediate
post operative Stress radiographs (Figure 7) did not reveal any opening of the
osteotomy site. This produced healing with no visible callus on radiographs (Figure
8) and better symmetric compression across the fracture site (Figure 9). 'Contact-
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healing' occurred at the cortical surface of plate application and 'gap-healing' was
seen on the far cortex opposite to that of the plate. This finding was similar to that
reported in the early studies of direct fracture healing that were performed in the
rabbit23, sheep28 and dog24'25. Osteonal remodelling units, 'cutting-cones', were seen
to traverse the fracture site (Figure 10, Figure 11).
(a) M (c) (d)
Figure 8: Plain radiographs following plate fixation (12mm x 3mm x 0.4mm) reveal no
external callus, apposition of bone fragments and restoration of tibial alignment, (a)
Immediate post-op (b) 2 wks post-op (c) 4 wks post-op (d) 6 wks post-op
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<<1)
Figure 9: Masson's trichrome stain at 6 weeks post rigid compression plate fixation (a) x4
magnification shows osteotomy fragments aligned with no external callus. On the upper aspect
note 'contact healing'on the cortical surface of plate application and 'gap healing' on the lower
cortex opposite plate application, (b) x20 magnification 'contact healing, (c) x20 magnification
'gap healing' with deposition of new bone parallel to the line of osteotomy. Yellow line scale at
100pm
<») (b)
Figure 10: Masson's trichrome at 6 weeks post rigid compression plating (a) x4 magnification
with 'cutting cone' (b) x20 magnification. Arrow shows osteonal remodelling unit traversing
osteotomy site. Yellow scale line indicates 100pm
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Figure 11: 'Cutting-cone' traversing osteotomy site in the rat model of direct fracture healing
developed in this study. Note leading osteoclast on the right and new bone deposition behind the
area of resorption.
The following table (Table 2) details the number of experimental animals and
cadavers that were used at each stage of implant refinement for the development of
this rodent model of direct fracture healing.
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Table 2: Implants used at each stage of refinement for development of the rat model of direct
fracture healing.
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Comparable Rat Model of Indirect Fracture Healing
The preservation of an adequate blood supply is crucial to fracture healing. The
external fixator model'2 that had been previously used in our lab140 involved
significantly less soft tissue dissection than the plating model. Therefore a model of
external fixation that used the same number and size of screw holes within the rat
tibia to that employed in our plating model was developed.
This external fixator model was based on that of a uniaxial external fixator routinely
used in clinical practice. Lengthier, 8 mm, Ml.2 screws were used to secure the 12
mm x 3 mm x 0.4 mm plate, that performed the function of a uni-axial fixator, at a
distance of 5 mm from the tibia. The plate was securely fixed to the screws with the
aid of a cyanoacrylate adhesive (Loctite ®).
To permit comparison of bisphosphonate effects on these two fracture healing
mechanisms the procedural aspects of the two fixation techniques were kept as
similar as possible.
As in the rigid plating model the external fixators were initially trialled in ten
cadaver tibia. On manual testing mobility was noted at the osteotomy site. When the
external fixator was applied to four live rats initially they were observed to mobilise




Final Surgical Techniques Used Following Model
Developments
Rigid Compression Plating of Rat Tibial Osteotomy
1. Animal weighed pre-operatively.
2. Inhaled Isofluorane for induction (5%) and maintenance (1-3%) of
anaesthesia.
3. Pre-operative antibiotic prophylaxis administered, 1 mL/kg Synulox s.c (1ml
Synulox contains 140mg Amoxicillin and 35mg Clavulinic Acid)
This antibiotic treatment has been shown to significantly reduce bacterial
counts in rat models of tibial staphylococcal osteomyelitis141 when compared
to other commonly used antibiotics.
4. Pre-operative fluids admistered, lOml/kg 0.9% saline s.c.
5. Analgesia, 0.05mg/kg buprenorphine s.c.
6. Animal positioned supine. Right hind limb shaved, prepped with aqueous
bethadine and a sterile drape applied.
7. 0.4mls/kg of 1% Xylocaine infiltrated into right hind leg prior to skin
incision. This provides regional anaesthesia and vasoconstriction that aids
visualisation of the operative field.
8. An antero-medial approach to the tibia exploiting the interval between tibialis
anterior and tibialis posterior 42 used.
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9. Then the custom made 4-hole jig (Physics Workshop, Edinburgh University,
UK) (Figure 13) was applied to the flat medial surface of the tibia and
secured to bone using two fine wires.
10. Four bone holes are drilled using a 1.0 mm drill bit powered with a hand-held
Dremmel® Multitool under constant cool saline irrigation through the jig.
11. A fine circular saw of 0.1 mm thickness (RS Components, UK. Kit no: 543-
967) used to create a transverse tibial osteotomy. The jig ensures compression
at the osteotomy site during plate application.
12. The periosteum was stripped circumferentially from the tibia at the level of
the osteotomy23 for the length of one diameter of the bone width at the
osteotomy site.
13. A pre-bent139 4-hole stainless steel plate (Physics Workshop, Edinburgh
University, UK ) measuring 12mm x 3mm x 0.4mm was applied to the
medial surface of the tibia with four 1.2mm x 4mm stainless steel screws
(PTS Etd, East Grinstead, UK) to obtain rigid stability and compression
across the osteotomy (Figure 15).
14. Following plate application the tibia was tested manually to assess mobility
at the fracture site. The fixation was deemed inadequate if displacement was
detected.
15. Wound closed with 3-0 vicryl.
16. Post-op Buprenorphine oral analgaesia (0.3mg/kg B.D) was administered in
jelly cubes for 24 hours.
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No restrictions to weight bearing were instituted. All animals were observed to be
weight bearing within 24 hours post operation.
mgm
I- 1 m .-j
I 1
10 iroi
Figure 13: Custom made 4-hole jig. Two holes on lateral surface for threading of fine wire to
help secure jig onto bone. Note there is also also a roughened surface to prevent the jig slipping
on bone during drilling.
(c) (d)
Figure 14: (a) Surgical approach (b) Custom jig (c) 4 drill holes on tibia (d) Osteotomy creation
under saline irrigation.
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Figure 15: Tibial plating showing anatomical alignment and compression at osteotomy site
External Fixation of Rat Tibial Osteotomy
Steps number 1 - 12 are performed as for rigid compression plating of a rat tibial
osteotomy described earlier.
13. A four-hole stainless steel plate, of the same dimensions as that used for
internal fixation, (Physics Workshop, Edinburgh University, UK ) measuring
12 mm x 3 mm x 0.4 mm was placed at 5mm distance to the medial surface
of the tibia with four Ml.2 x 8 mm stainless steel screws of (PTS Ltd, East
Grinstead, UK).
14. To prevent the plate from sliding on the screws Loctite® adhesive was
applied to fix the plate to the screw heads.
15. Wound closed with interrupted 3-0 vicryl. The skin between each screw was
approximated with a single stitch.
16. Post-op Buprenorphine oral analgaesia (0.3mg/kg B.D) was administered in
jelly cubes for 24 hours.





Animal Randomisation in to Experimental Groups
All animal procedures adhered to the Animals (Scientific Procedures) Act 1986 and
were approved by the appropriate local and national authorities. Animals were fed
standard rat chow and provided with water ad libitum. Animals were housed in
individual cages at constant temperature (21 + 1 °C) and humidity (45% - 55%) using
a 12 hour light/dark cycle. Following one week of housing to allow for
acclimatisation to their new environment animals were randomly allocated to the
experimental groups, as will be described later. Daily subcutaneous (s.c.) injections
were then commenced for 3 weeks prior to operative fixation of a transverse tibial
osteotomy. 6 weeks post surgical fixation animals were sacrificed (Figure 16). The
mode of fracture fixation and daily injection varied according to the group that the
animals were allocated to. All animals were weighed at weekly intervals.
Figure 16: Timeline for animal surgery
Skeletally mature ex-breeder male rats aged between 11-13 months were used. A
total of 36 animals were used. The optimal daily subcutaneous dose of Ibandronate to
prevent bone loss in ovariectomised rats is lpg/kg 143 and was therefore used in this
study. The Ibandronate was purchased in pre-filled syringes from Roche as
Bonviva®. Each syringe contained 3mg of Ibandronic acid in 3mL of solution (as
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3.375mg of ibandronic acid, monosodium salt, monohydrate). The excipients within
the solution are sodium chloride, glacial acetic acid, sodium acetate trihydrate and
water for injection. The contents of each pre-filled syringe were diluted in isotonic
saline to achieve the necessary concentration required for animal injection:
lmL Bonviva® (lmg/mL Ibandronic acid) diluted in 499mL isotonic saline
, this produced; lmg/mL Ibandronic acid in 500ml isotonic saline
, this equals; lpg Ibandronic acid in 0.5mL isotonic saline
, therefore the daily volume of Ibandronate injection that each animal received was
calculated as; 0.5mL x Animal Weight (in kilograms).
All animals were given a unique identification number. A card was created for each
animal and all cards were mixed and placed in a box. Cards were randomly picked
from this box and in this manner animals were randomly allocated to two groups of
ten and two groups of eight. The two groups of ten were allocated to internal fixation
(direct fracture healing). The two groups of eight were allocated to external fixation
(indirect fracture healing). In both the direct and indirect fracture healing groups
respectively, there was a placebo control group and a continuous bisphosphonate
therapy group. For each group of animals half the number of animals were randomly
allocated, similarly by picking numbered cards that were mixed in a box, for either
mechanical testing or histological analysis of the healing tibial osteotomy following
sacrifice.






Experiment 1 - Placebo Control 3 weeks of daily 0.5mL s.c
injections of isotonic saline,
osteotomy and stabilisation at day
21, then a further 3 weeks of daily
s/c saline injections
10 8
Experiment 2 - Continuous
Bisphosphonate Treatment
3 weeks of daily s/c lpg/kg
Ibandronate, osteotomy and
stabilisation at day 21, then a
further 3 weeks of daily s.c
Ibandronate injections
10 8
Table 3: Experimental Groups
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Sample Size Calculation
Restoration of function is the goal of fracture care. Stability at the healing tibial
fracture site is the key element that permits weight bearing and is best assessed on
mechanical testing. Mechanical testing also enabled direct comparison using
identical methods between the two fracture healing mechanisms. Therefore, the
primary outcome measure in this study was biomechanical testing.
The Act of Parliament governing the use of animals in scientific research states that
a minimum number of animals consistent with a statistically significant result should
be used (Home Office (HMSO) 1986). A sample size calculation was performed to
ascertain the minimum number of animals required to detect a statistically significant
difference. Sample size calculation was performed using MedCalc Software version
11.3.8 (Mariakerke, Belgium).
Based on results from a previous study144 conducted within this research group
using a rat tibial fracture model that revealed mean(+SD) following fracture healing
in the control group as 150(±8.05)Nmm"2 a sample size of four per group was needed
to detect a difference of 15% (20 Nmrn2) in means using a two-sided, two-sample t-
test with a 5% level of significance and an 80% power.
In order to ensure that there was a minimum of four animals for biomechanical
testing and a further four for histological analysis at the end of the experimental
period, ten animals were used in the plate fixation group and eight in the external
fixation group. Due to the more complex procedural aspects of internal fixation it
was anticipated that there may be a greater likelihood of failure therefore additional
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The mechanical properties of the healing tibial osteotomies were assessed using
four-point bending.
Testing Apparatus
Mechanical testing was performed using a custom made jig (Figure 17) previously
designed by University of Edinburgh Physics Workshop, Kings Buildings,
Edinburgh for testing rat tibiae in four-point bending144 in conjunction with a
Zwick/Roell Z005 materials testing machine. The upper rig was designed to
incorporate a pivot to ensure an equal application of force at all 4 loading points"3
during the bending tests of rat tibiae, which were irregularly shaped. The upper
loading span was spaced 10 mm apart and the lower static span was spaced 20 mm
apart. Contact points were rounded to minimise notching of the bone after load
application.
Figure 17: Mechanical testing jig and sequence of 4-point bending test
The Zwick/Roell Z005 material testing machine had a load cell of 10 kN and load
was applied at a rate of 10 Ns"1. A stiff load cell in relation to bone was used to
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eliminate deformation in the testing apparatus. Therefore, the deformation noted
would be primarily within the bone tested.
Specimen Storage
Following sacrifice of animals at six weeks post osteotomy, tibiae were collected
after careful dissection of soft tissues then stored in 0.9% Saline and frozen at -20°C,
prior to performing mechanical tests within three weeks.
Specimen Preparation
Specimens in frozen saline were warmed within individual tubes in a water bath set
at 37°C for at least 30 minutes prior to mounting on the testing apparatus for four-
point bending.
Specimen Testing
Tibiae were mounted horizontally with the lateral surface resting on the lower rig.
This position was adopted as the tibiae were found to be stable on the testing
apparatus in this orientation. The vertical distance from the medial tibial plateau to
the healing osteotomy was measured with calipers and recorded. The site of the
healing osteotomy was positioned to lie in the middle of the two lower loading
points. In the contra-lateral tibia, a site corresponding to the vertical distance of the
healing osteotomy from the medial tibial plateau was marked with a pencil.
Similarly, this site was positioned in the middle of the two lower loading points.
All specimens were tested to failure. A load-deflection curve was obtained for each
specimen during mechanical testing. A typical load-deflection curve that was
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obtained for a healing osteotomy (Chart 2) and intact tibia (Chart 3) are shown
below. Note that for the healing osteotomy that there was no distinct yield point
indicating that specimen failure occurred at the point of ultimate load that was not
distinguishable from the yield point. In the intact tibia the yield point was noted to be
distinct from the ultimate load at failure.
0.00 0.20 0.40 0.60 0.80 1.00
Deflection (mm)
Chart 2: Typical load-deflection curve obtained for a healing tibial osteotomy. Note no distinct
yield point that is separate to point of ultimate load.
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Chart 3: Typical load-deflection curve obtained for intact tibia.
Work-to-Failure
In the intact tibia, the area under the load-deformation curve was measured to
quantify work to failure. This represents the amount of energy required to create a
fracture in the bone.
Physical Measurements of Bone following Mechanical Test to Failure
Digital images obtained following preliminary bending test on cadaveric tibiae
kindly donated by the Biological Research Facility (BRF), The University of
Edinburgh revealed that the cross section of the rat mid-tibial shaft most closely
resembled a triangle (Figure 18).
Measurements were made of the distal segment of bone after mechanical testing to
failure. The sagittal and coronal widths which corresponded to the external vertical
height (//) and external base length (B) of the triangular cross section (Figure 18)
were obtained using sliding callipers. A digital image (Canon Digital IXUS 75
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camera) of the distal segment cross section for each sample was obtained. These
images were printed and the vertical height and base length of the triangular cross
section for the whole bone and the intramedullary canal were measured manually.
The scale for the digital image was obtained by comparing the external widths
previously measured with the callipers to the readings obtained from the image. The
internal vertical height (h) and base length (b) of the triangular intramedullary cross
section were then calculated. The triangular cross sectional area of the whole bone
and intramedullary canal were then derived. This was used to obtain the cross
sectional moment of inertia(Z) that was required to calculate the stress(o), according
to the elastic beam bending theory.
/\
\ /
Figure 18: Cross section of tibia. H = external vertical height, B= external base length, h= inner
vertical height, b= inner base length
Cross Sectional Moment of Inertia
The maximum stress at failure for the bone in bending test was related to its
material properties and its physical shape. Bending caused predominantly tensile
forces at the convexity and compression within the concavity in the plane of bending.
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These forces were greatest at the bone surface and absent at the centre of mass (the
neutral axis). The cross-sectional moment of inertia (/) is a property of a shape that is
used to predict its resistance to bending and deflection based on the distribution of
the shape surrounding the neutral axis in bending"3.1 is required to calculate stress.
The cross section of the mid tibial shaft most closely resembles a triangle (Figure
18). Therefore the cross-sectional moment of inertia was calculated for a triangular
cross section using the following formula145:
Figure 19: Diagram of 4-point bending with explanation of abbreviations used in equations to
calculate stress, and theoretical strain.
F - Applied force
a = Distance between the inner and outer loading points = 5mm
H = Vertical height of triangular cross section








Stress is defined as the force applied per unit area. The elastic beam bending theory





The applied moment, M - — x a
The applied force is halved as it is distributed between two points of load application
h
The distance from the neutral axis, Y = —
3
For a triangular cross-section, the neutral axis is 1/3 of the way between the base and
the vertical height to the apex of the triangle.
Therefore, the equation used in this particular experiment to calculate stress was:











During bending tests it was observed that specimens failed in tension (Figure 17).
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In addition to the assumption that rat tibiae have a triangular cross section at the
mid-shaft, the following standard assumptions for the elastic beam bending theory
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were used :
1. The span did not change during the test
2. No horizontal stresses developed at the supports
3. No stress concentrations developed at the contacts
4. The slope of the neutral axis was small at all points compared to unity
5. The strain of any "fibre" was proportional to its distance from the neutral axis
6. Shearing stresses were negligible
7. The loads were in one plane and perpendicular to the neutral surface
8. The beam was narrow.
The stress at failure as a surrogate of absolute bone strength was calculated and
recorded for each specimen.
Theoretical Strain
Strain is defined as the proportion change in length or relative deformation.
Theoretical strain (s) was calculated using the following equation for 4-point
loading"3:




Following calculation of stress and theoretical strain a stress-strain curve was
produced for the intact tibia. The area under the curve to the point of ultimate stress
was used to quantify toughness (m)146. This represents the quantity of energy
absorbed per unit of bone prior to failure.
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Radiography
Serial Radiographs of Healing Osteotomies
In order to assess the progression of fracture healing serial plain radiographs were
obtained for all animals. Plain radiographs were taken immediately post-operatively,
thereafter at two, four, and six weeks post-operatively. Plain radiographs were
obtained using a portable X-ray unit (Acu-Ray JR, Stern Manufacturing Toronto,
Canada) with an output of 60 kV and exposure time of 0.1ms. Images were captured
on digital x-ray plates (Fuji IP Cassette, Fuji Photo Film Co Ltd Japan).
Standardised antero-posterior (A-P) radiographs were obtained. Under general
anaesthesia the animals were placed supine on the x-ray plates. The hip and knee
were flexed to 90° and the ankle was grasped with a padded retort stand (Figure 20).
The x-ray beam was positioned at a fixed distance, 78cm from the plate.
Figure 20: Rat positioning to obtain standardised antero-posterior radiograph of tibia
Serial radiographs were qualitatively assessed looking in particular for maintenance




In the external fixator groups the callus index was measured in serial radiographs at
two, four and six weeks post osteotomy to assess the progression of fracture healing.
Using Image-J software (National Institutes of Health, USA) the maximum callus
diameter (c) and bone diameter (b) were measured (Figure 21) in pixel units. The
callus index was calculated as follows:
c
Callus index = —
b
Where, c = Maximum diameter of callus.
b = Diameter of diaphyseal bone at similar level to callus.
Figure 21: A diagram of the method used to determine callus index
Radiographs of Extricated Tibiae
Following sacrifice at six weeks post osteotomy, tibiae were carefully dissected of
soft tissue and metalwork removed. Plain radiographs were obtained using a portable
x-ray unit (Acu-Ray JR, Stern Manufacturing Toronto, Canada) with an output of 60
kV and exposure time of 0.1ms. Images were captured on digital x-ray plates (Fuji IP
Cassette, Fuji Photo Film Co Ltd Japan). The x-ray beam was placed at a fixed
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distance of 78 cm from the x-ray plate. The bones and an aluminium step-wedge
consisting of ten, 1 mm steps, were placed on the x-ray plate for image capture.
Lateral radiographs of both tibiae in each animal were obtained to exclude the effect
of fibula overlay. The aluminium step wedge was used to peform radiographic
analysis of bone density as will be described later
Visibility ofOsteotomy Site
The visibility of the healing osteotomy sites were scored as absent (0), partially
visible (1) or totally visible (2) as previously described61'130 (Figure 22). The
radiographs were scored by two assessors on two separate occasions independently.
The radiographs were randomised and the assessors were blinded to the fixation
method and bisphosphonate dosing regimen. One of the assessors was the author and
the other an orthopaedic trainee who did not have any other involvement in this
study.
Absent Partially Visible Totally Visible
Figure 22: X-rays of extricated tibiae demonstrating scoring for visibility of osteotomy
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Callus Width
The maximum sagittal callus diameter (Figure 23) was measured from a contact
lateral radiograph of the extricated tibiae from the external fixation groups following
sacrifice at six weeks post osteotomy. The maximum coronal callus width was
measured from the A-P radiograph at 6 weeks post-osteotomy as described
previously in the section on callus index (Figure 21).
Figure 23: A diagram of method used to measure sagittal callus width
Radiographic Analysis ofBone Density
An aluminium step-wedge (Figure 24) consisting of ten, 1mm steps was placed near
the area of interest in each intact limb x-ray. Image analysis was performed in
MATLAB® (The MathWorks, Inc. MA, USA). Each radiograph was corrected for
background variation due to the Anode-Cathode Heel effect by the fitting and
subtraction of an exponential model to the intensity profile in a blank area of the
image. A calibration graph of Aluminium step thickness (mmAl) versus the grey
level in each step of the step wedge was then made. This was fitted with an
exponential curve and provided a calibration between measured grey level and
Aluminium equivalent (Al.Eq) density for any point on the radiograph147.
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Figure 24: Aluminium step wedge with ten, 1mm steps
In the uninjured contra-lateral limb of the continuous bisphosphonate treatment and
placebo groups the point where the fibula joined the tibia distally was marked. A 100
x 50 pixel box was marked from this point to include the mid-shaft of the bone. To
assess bone density, an average grey level of the diaphyseal tibia within this box was
measured. This measured grey level was then converted to an Aluminium Equivalent
(Al.Eq) density as previously described.
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Histology
This was performed to assess morphology at the fracture site. In order to obtain
sections with optimum preservation of cellular architecture samples were fixed in
formalin, decalcified and embedded in paraffin.
Fixation
At 6 weeks post-osteotomy, following sacrifice the tibiae and fibulae from each
animal were dissected out. Within 30 minutes of extrication, the specimens were
immersed in 10% formalin in phosphate buffered saline at pH 7.2-7.4 for 48 hours.
Decalcification
Based on a previous experiment144 all specimens were decalcified for 4 weeks in
EDTA at pH 7 and 37°C with weekly changes of EDTA. Complete decalcification of
initial specimens were verified using a table top x-ray unit (Faxitron, USA)
Processing
Following decalcification an automated processor was used to prepare specimens
for embedding in paraffin. The processing protocol is shown in Appendix 1. The
specimens were mounted in paraffin blocks and orientated vertically to permit
longitudinal cross sections of the tibia to be made in the coronal plane.
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Sectioning
5pm sections were cut on a standard microtome (Shandon). After floating on
deionised water at 40°C to remove ridges, sections were mounted on 'Superfrost
plus' slides (BDH). Slides were stood vertically to dry and then baked at 37°C for 12
hours to increase section adherence. All slides were then stored in a dry, dark
environment at room temperature until used in histological procedures.
Analysis of Sections
For this study coronal sections of the tibia were chosen as this allowed visualization
of the cortical surface of plate application and the opposite far cortex with the
intervening intramedullary space in a single view. This permitted examination for the
presence of external callus, contact healing on the plate surface and gap healing on
the far cortex.
In order to study the general morphology of the healing fractures a series of coronal
sections were made at three sites. To avoid sections that were solely within the
anterior cortex, the first site was 100pm from the anterior cortex. After leaving a
space of 500pm the second series of sections were made and finally the third series
of sections was similarly spaced 500pm apart. Each site was spaced 500pm apart to
assess variability within the specimen. Serial 5pm coronal sections were made at
each point to permit the use of 2 staining techniques (H&E and Masson's
Trichrome). All slides were assessed in a blinded manner following randomisation.
On completion of the first series of experiments with rigid plate fixation where
animals either received placebo or continuous bisphosphonate therapy a random
sample of twenty slides, one-third of specimens, from these animals were presented
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to a musculoskeletal pathologist who had not been involved in the experimental
study design and execution to assess the general morphology at the fracture site. This
was to ensure that an independent assessor evaluated the specimens qualitatively in
an unbiased manner.
Similarly in a blinded and randomised manner all slides were assessed by the author
and the pre-dominant tissue type at the fracture site was evaluated and reported as
cartilage(l), undifferentiated mesenchymal tissue(2), or bone(3). The mode of the
tissue type that was predominant amongst the slides for each animal was used in
subsequent analysis. Furthermore, the presence or absence of new bone formation





All animals were fully weight bearing within 12 hours post-operatively. Animal
weights remained relatively unchanged during the 6 week period post fracture
stabilisation prior to sacrifice.
Exclusions
One animal in the control ex-fix group (SX05) developed a wound infection in the
first week post operatively. This animal was treated with daily subcutaneous
injections of antibiotics (Synulox) and within four days there were no visible signs of
infection. When the external fixator was removed, on animal sacrifice, there was
gross mobility at the fracture site. Therefore this animal was excluded from
subsequent data analysis. In another animal in the control ex-fix group (SX06), the
fixation failed at two weeks post op with marked angulation and displacement at the
fracture site. Due to fixation failure, no subsequent analysis was performed for the
injured limb in this animal.
In the plate fixation group an animal in the control group (SOI) had an abnormally
high force at failure of the healing osteotomy. On close inspection of the serial
radiographs and lateral contact radiographs, the posterior cortical hinge was intact
suggesting that the osteotomy was not completed posteriorly. External callus was
observed on the posterior cortex of one animal in the bisphosphonate plating group
(C02) on contact radiograph following sacrifice and plate removal. This was likely to
have occurred due to inadequate stripping of the periosteum on the posterior surface
of the tibia where there is a broad and more extensive attachment from the deep
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Injured Limb
Following sacrifice, at 6 weeks post osteotomy and stabilisation, tibiae were
extricated. After careful dissection of soft tissues, the metalwork was removed in the
injured limbs. A standardised contact lateral radiograph was obtained, then
specimens were either tested to failure with four-point loading or processed for
histological analysis as per randomisation at the onset of the experimental procedure.
Mechanical Testing
In the direct healing group, mechanical testing data was available for analysis from
four animals respectively in the control and bisphosphonate treatment groups. Two-
sided, two sample r-tests were used for comparison of the mean values between each
of the two groups. The control plate group had a statistically significant, p = 0.017,
higher mean (±SD) stress at failure 24.65 (+6.15) Nmm"2 compared to the
bisphosphonate treated plate fixation group 8.69 (+7.63) Nmm"2.
In the indirect fracture healing group, the mean (+SD) stress at failure for the four
animals where mechanical testing was performed in the bisphosphonate treated
external fixation group was 28.70 (+16.15) Nmm"2. Due to infection and fixation
failure, there were only two animals in the control external fixation group where
mechanical testing data was available. The stress at failure in these two animals
SX02 and SX07 respectively were 23.94 Nmm"2 and 19.71 Nmm"2. There was a
trend towards a greater stress at failure for the bisphosphonate external fixation
group compared to the bisphosphonate plating group, p = 0.066. The stress at failure
was similar between the bisphosphonate ex-fix and control plating groups. The
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distribution of the stress at failure values for the healing tibial osteotomies are
presented in Chart 4. All mechanical testing measurements are listed in Appendix 2
Nmirr2 60

















Chart 4: Distribution of stress at failure values for healing tibial osteotomies
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Radiography
Serial Radiographs ofHealing Osteotomies
Serial antero-posterior (A-P) radiographs of healing osteotomies in the control and
bisphosphonate plating groups revealed no evidence of external callus formation
(Figure 25). One animal in the bisphosphonate plate group had callus on contact
radiographs following sacrifice and plate removal. This animal was excluded from
analysis as previously described in the section on 'Exclusions' above.
In the external fixation groups the A-P radiographs revealed external callus
formation (Figure 26). In one animal in the control external fixator group that
developed an infection (SX05) there was marked resorptive changes on the serial A-
P radiographs from the second post-operative week onwards. In the other animal
within the control external fixator group that was excluded from subsequent analysis
(SX06), there was marked angulation and displacement at the fracture site from the
second post-operative week onwards.
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Post-op 2 wks 4 wks 6wks
Figure 25: Serial x-rays of a bisphosphonate treated animal with rigid plate Fixation. Note no
external callus formation and anatomical reduction, but persistence of fracture line.
Post-op 2 wks 4 wks 6wks
Figure 26: Serial x-rays of an animal with external fixator stabilisation of tibial osteotomy. Note
external callus formation.
Callus Index
The callus index was measured at 2, 4 and 6 weeks for animals in the external
fixator groups. The callus index in the control animals (Chart 5) that received saline
injections appeared to peak at week 4, then declined at the 6 week stage. In contrast
the callus index of osteotomies stabilised with an external fixator in animals that




Chart 5: Serial measurements of callus index in the control external fixator group indicating a
peak in callus index at between 4 to 6 weeks post osteotomy.
Chart 6: Serial measurements of callus index in the ibandronate external fixator group
indicating callus index continues to rise after 4 weeks.
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Callus Width
Radiographic measurements of the callus width were made for the external fixator
groups. Coronal width was measured from the antero-posterior x-ray at 6 weeks.
Sagittal width was measured from the lateral x-ray following sacrifice and implant
removal.
The mean(±SD) for the coronal and sagittal callus width in the control external
fixator group was respectively 4.49(+0.78) pixel units and 4.62(±1.04) pixel units.
For the ibandronate external fixator group the mean(±SD) coronal and sagittal widths
were 5.04±(0.67) pixel units and 5.17(±1.27) pixel units. A two-sided, two sample t-
test revealed no statistically significant difference in these measurements between the
two groups.
The callus index and callus width measurements are listed in Appendix 3.
Visibility ofOsteotomy Site
The Kappa values were used to assess for inter and intra rater agreement for
osteotomy line visibility There was good inter-rater agreement for the assessment of
fracture line visibility between the two observers with a k value of 0.77 (95%
confidence interval (CI) 0.59 to 0.94). Similarly, there was good intra-rater
agreement for both observers [Author (k=0.87, 95% CI 0.74 to 1.00), Independent
assessor (k=0.64, 95% CI 0.43 to 0.86).
Contact radiographs following 6 weeks of fracture healing showed that the
osteotomy line remained more clearly visible in the bisphosphonate plate group
compared to the control plate group. The score, 'absent' (0), was not used by either
observer for the bisphosphonate plate group animals but used to describe 4 to 6 of 9
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animals in the control plate group on each occasion (Table 4). Chi square tests
showed that this difference was statistically significant (p < 0.01).
Comparison of osteotomy line visibility in the indirect fracture healing groups
revealed no difference between animals treated with bisphosphonate and controls
that received saline injections (Table 5). All scores for the visibility of the osteotomy













Bisphosphonate 0 4 5
<0.005Control 5 4 0
2nd
assessment
Bisphosphonate 0 4 5





Bisphosphonate 0 3 6
<0.005Control 5 4 0
2nd
assessment
Bisphosphonate 0 5 4
<0.005Control 6 3 0
Table 4: Number of animals in each group based on the visibility of the osteotomy site as scored














Bisphosphonate 0 5 3
0.687Control 0 4 2
2nd
assessment
Bisphosphonate 0 4 4





Bisphosphonate 1 3 4
0.459
Control 0 4 2
2nd
assessment
Bisphosphonate 0 4 4
0.469
Control 0 5 1
Table 5: Number of animals in each group based on the visibility of the osteotomy site as scored
by two observers on two separate occasions for animals treated with external fixation.
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Histology
Based on the general appearance at the fracture site an independent assessor (a fully
qualified musculoskeletal pathologist) when viewing a sample of slides from the two
plating groups (placebo control and continuous bisphosphonate treatment groups), in
a blinded fashion, was able to allocate all slides into two distinct groups. All slides
within the first group, where there was less fracture repair activity, were from
bisphosphonate treated animals. The other group of slides consisted wholly of
specimens from controls. There were no slides that were not clearly distinguishable
between the groups (Figure 27)
The predominant tissue type was bone in all five control plate fixation animals. In
the bisphosphonate plating group, three animals had predominantly cartilage like
tissue at the fracture site and the remaining two assessed had predominantly
undifferentiated mesenchymal tissue. A chi-squared test revealed a p-value of 0.007
indicating a significant difference in the predominant tissue type at the osteotomy
site between the bisphosphonate plate and control plate groups. In only two of five
animals in the bisphosphonate treated plating group was there histological evidence
of new bone formation across the osteotomy.
In the indirect fracture healing groups, the predominant tissue type across the
osteotomy site in all animals was undifferentiated mesenchymal tissue. There was
new woven bone formation within the callus of all animals treated with external
fixation, both in the control and in the bisphosphonate treated animals (Figure 28)
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(a) (b)
Figure 27: Masson's Trichrome (x4) magnification, (a) Control plate fixation. Note primary
healing with bone formation, (b) Bisphosphonate plate fixation. Note little activity at the




Figure 28: Masson's Trichrome (x4) magnification, (a) Control external fixation. Note woven
bone formation within external callus, (b) Bisphosphonate external fixation with rim of external
callus and new woven bone formation, in contrast to (c) Bisphosphonate plate fixation with little




Mechanical testing data was available for the uninjured tibia for 14 animals that
received daily bisphosphonate therapy and for 17 animals that received placebo
saline treatment. Two animals in the bisphosphonate group (CX07 and CX08) were
excluded from analysis, as failure of the intact tibia occurred in a mode not consistent
with bending stress.
Two-sided, two sample r-tests were used to assess for differences between the mean
values of mechanical parameters that were analysed between the two groups. The
bisphosphonate group had a statistically significant, p=0.006, higher mean (±S.D)
stress at failure 219.2 (±45.99) Nmm"2 compared to the placebo group 169.5 (±43.32)
Nmm"2 (Chart 7). There was no significant difference in toughness between the
bisphosphonate treated group in comparison to placebo controls [Bisphosphonate v.
Placebo = 2.51 (±1.74) MJmm3 v. 1.67(±0.86) MJ/mm"3j. Similarly there was a
greater, but not statistically significant, mean work-to-failure in the bisphosphonate
group compared to placebo controls [76.37 (±50.74) J v. 52.94 (±23.94) J], The
deflection to the point of failure was greater in the bisphosphonate group but not
significantly different [Bisphosphonate v. Placebo = 0.68(±0.23) mm v. 0.55(±0.27)
mm].
There was no statistically significant difference in the physical measurements of
bone width (two-sided, two sample Mest). The mean (±SD) coronal bone widths for
the bisphosphonate v. placebo control groups respectively were 3.7 (±0.83) mm v.
3.8 (±0.62) mm and the mean sagittal bone widths were 2.7 (±0.24) mm v.
134
3.0(±0.21)mm. There was no difference in the cross sectional moment of inertia












Chart 7: Mean bending stress at failure following application of a 4-point bend in uninjured
contra-lateral tibial diaphysis. Bars indicate (± SD).
Radiographic Analysis of Bone Density
There was no statistically significant difference in the mean (±SD) Al.Eq density at the
tibial diaphysis [Bisphosphonate v. Placebo = 1.53(+0.24) v. 1.76(+0.33)]. A scatter plot of
the relationship between Al.Eq density and stress at failure is presented in Chart 8.
Regression lines plotted on Microsoft Excel 2007 suggest a steeper gradient for the IBAN









A Rodent Model of Direct Fracture Healing
Previous studies of healing tibial fractures in rats have solely assessed indirect
fracture healing. In this study, a model of direct fracture healing in the rat that
resembles operative fracture fixation seen in routine clinical practice has been
developed. A transverse tibial osteotomy is rigidly fixed with compression plating
similar to that used in routine clinical practice for operative fracture management.
This simple reproducible rodent model of direct fracture healing may be used in the
future study of direct fracture healing.
The histological appearance of the healing rat tibial osteotomies was similar to that
previously reported in the early descriptions of direct fracture healing in the dog24'25,
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sheep" and rabbit ' . 'Contact-healing' with 'cutting-cones' traversing the
osteotomy predominated at the cortex adjacent to the plate and 'gap-healing'
occurred at the far cortical surface with new bone formation observed to be
orientated parallel to the osteotomy line.
Due to decreasing societal acceptance it is difficult to perform fracture healing
studies in domestic animals. There are also fewer animal research facilities that
house domestic animals. The animal costs for larger farm animals are significantly
greater. The animal cost for the work carried out in this thesis would have been
threefold greater if performed using rabbits. Furthermore there has been a large
number of recent fracture healing studies that used rat models of indirect fracture
healing1". The existence of a rat direct fracture healing model will permit the use of
recently developed methods to study rat fracture repair to be applied to further
investigations that concern direct fracture healing.
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A recent plate fixation model of a mouse femoral osteotomy92 described earlier
radiological healing and greater fracture stiffness with a non-destructive bending test,
in comparison to less rigid fixation with an intra-medullary device. The intra¬
medullary device had a cone shaped head and proximal thread to provide better
rotational control of the osteotomy. Assessments were made at two and five weeks
post osteotomy. On histology, some external callus was observed and no osteonal
remodelling units ('cutting-cones') were demonstrated that traversed the fracture site.
It may be that earlier histological analysis within the first two weeks would have
revealed cartilage. A previous model of intramedullary fixation in murine tibial
fractures found that the slope for the proportion of cartilage composition within the
fracture callus was increased up to day-7. There was a continued increase in the
proportion of cartilage with a decreased gradient in the slope up to day-9 post
fracture and a reduction by the next measurement at day-14 post fracture. This
indicated that the peak cartilage content would have been observed at a point
between day-7 and day-14 post fracture. The reported ultimate bending load and
bending stiffness in this study increased sharply from day-7 onwards which would be
consistent with the commencement of callus mineralisation and decrease in cartilage
deposition as found on histology91. A similar observed improvement in mechanical
properties of murine fractures have also been reported by Cheung et al94 in a model
of external fixation after day-7 post fracture. The model of Histing et al92, therefore
appears to be a good model of intramembranous ossification but not of direct fracture
healing with 'cutting-cones'. They also noted surgical failure in four of 20 animals
described as implant dislocation during fixation.
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The model reported in this thesis reliably produced healing without callus. The
observation of minimal external callus on the posterior cortex of the tibia in one
animal, early in the series, may have been due to inadequate periosteal stripping
adjacent to the osteotomy on the posterior tibial surface. This area was difficult to
visualise fully. However, adequate stripping of the periosteum here may be
especially important due to the broad attachment of the deep posterior compartment
muscles to the posterior tibia. Therefore, care should be taken to ensure the
periosteum is stripped adjacent to the osteotomy, in particular on the posterior tibial
cortex. In this study the length of periosteum for only one diameter of the bone width
at the osteotomy was stripped on either side of the osteotomy. This was to prevent
excessive disruption to the periosteal blood supply and is less than the periosteal
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stripping of twice the diameter of bone that was performed by Rahn et al and
Ashhurst et al29 in the previously described model of direct fracture healing in the
rabbit.
Indirect fracture healing via callus formation in the long bone of an adult rat has
been reported to take up to 12 weeks prior to the restoration of mechanical properties
similar to the uninjured side148. The process of direct fracture healing proceeds to
completion through a lengthier time course1'3. Therefore, at six weeks post fracture
fixation the strength of the rigidly fixed healing tibial osteotomies would not be
expected to be similar to that of the contra-lateral limb. At the six week stage the
mean load of failure of the rigidly plated rat tibial osteotomies in this study was
similar to the mean value of 27.5 N as previously reported in a model of non-rigidly
fixed healing rat tibial osteotomies61. The values for stress at failure of the healing
osteotomies were similar to that obtained by Bak et al." via three-point bending in
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their rat tibial fracture model that healed with callus formation. At six weeks Bak et
al" noted a mean proportional strength of 12.2% for their healing fractures compared
to the contra-lateral tibia. The mean proportional strength of the rigidly plated
healing rat tibial osteotomies within the plate control group, in this study was 15.2%.
Therefore the rigid plating model that has been developed enables direct fracture
repair that is quantifiable in 4-point bending tests with failure load values at six
weeks post plating that are comparable to that which has been previously reported in
non-rigid fracture repair models in the rat.
The surgical procedure could be simplified by the development of a miniature
dynamic compression plate that is comprised of oval holes with sloped edges. The
finding that direct fracture healing occurs in the rat as seen in this study may be
justification for future work to refine the plate as this may enable fixation of rodent
tibial fractures of differing configurations with greater ease.
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The Effects of Bisphosphonates on Direct Fracture Healing
There have been no papers describing the effects of bisphosphonate on fracture
healing with plate fixation. There is however one published abstract on this topic110.
Cynomolgous monkeys were administered alendronate, a nitrogen containing
bisphosphonate, in a low and high dose for three weeks prior to femoral osteotomy
and plating. Alendronate therapy was continued post femoral plating for a further 26
weeks. The authors report that stress at failure following a high dose of alendronate
therapy was significantly lower than controls. In both alendronate treatment groups
there was a larger callus volume, with a greater proportion of woven to lamellar bone
and decreased bone formation rate. The abstract does not provide any detail on the
plate used for fracture stabilisation and does not mention rigid fixation. It is of
particular note that the abstract suggests that all animals had visible external callus
formation indicating that this was therefore not a model of direct fracture healing.
Here a model of rigid tibial plating has been used where no external callus was
noted on serial radiographs of all animals in the control group and bone repair
occurred by direct healing with 'cutting-cones' tunnelling across the fracture site. In
addition the effects of bisphosphonate therapy has been assessed in a model of non-
rigid fixation, where an external fixator was used to stabilise a standardised tibial
osteotomy using a similar surgical approach and the same number and size of screw
holes for bone fixation.
In the direct fracture healing group, animals treated with bisphosphonate had a
statistically significant lower mean stress at failure of the healing osteotomies.
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Furthermore, in the bisphosphonate treated animals the fracture line was more clearly
visible and the histological appearance of predominantly cartilage and
undifferentiated mesenchymal tissue with a lack of new bone formation was
indicative of impaired fracture healing.
These findings suggest that bisphosphonate treatment in a therapeutic dose, as used
for fragility fracture risk reduction in osteoporosis, had an inhibitory effect on direct
fracture healing as evident on mechanical testing, radiographs and histology.
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The Effects of Bisphosphonate on Indirect Fracture Healing
There was no significant difference in the radiological and histological appearance
of the non-rigidly fixed healing osteotomies between the bisphosphonate treated
animals and controls. Due to post-operative complications there were insufficient
animal numbers for meaningful comparison of the bisphosphonate effect on the
mechanical properties of the healing osteotomies in the indirect fracture healing
group but reports in the literature19'59 67 68 indicate that bisphosphonate administration
in a therapeutic dose does not impair the mechanical properties of healing fractures
and results in a larger external callus bulk.
It has been suggested that callus size peaks at a point that coincides with callus
remodelling. This is based on serial measurements of increasing callus size on
radiographs in association with improved patient function5'128, increased in vivo
fracture stability in a clinical study5 and on increasing failure load of experimental
tibial fractures129. The timing of the peak in callus size at day-21 post experimental
tibial fractures that corresponds with the initial peak fracture failure load has been
observed to coincide with the onset of callus remodelling on histological assessment
of healing experimental tibial fractures2.
The finding that callus index peaks at between four to six weeks post-fracture in the
non-rigidly fixed controls but continued to rise up to six weeks post-fracture in the
bisphosphonate treated animals suggests that bisphosphonate treatment delays the
onset of callus remodelling. This is in keeping with previously published findings
1 Q fL--J ZTQ "71
that indicate bisphosphonate treatment delays callus remodelling ' ' ' ' in indirect
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Clinical Relevance of Bisphosphonate Inhibitory Effect on
Direct Fracture Healing
Currently displaced forearm diaphyseal fractures in adults are nearly always treated
with anatomical reduction and rigid fixation whereby direct fracture healing
predominates. This is to permit early mobilisation of the upper extremity and
enhance functional recovery. The presence of external callus may cause a mechanical
block to forearm rotation with corresponding functional restrictions. Displaced
humeral shaft fractures may be treated with rigid plate fixation. Recent clinical
studies suggest that humeral plating is associated with less perioperative
complications in comparison to non-rigid, intramedullary nail fixation but with
similar longer term functional scores149'150. The AO philosophy that largely
influences operative fracture treatment recommends anatomical reduction and rigid
fixation of articular fractures to prevent premature articular cartilage degeneration as
a result of abnormal point loading with a malunited fracture31.
Over a one year period at the Trauma Unit of the Edinburgh Royal Infirmary
between 4th July 2007 and 3rd July 2008 there were 67 adult forearm diaphyseal
fractures and 66 humeral diaphyseal fractures treated. The following two graphs
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Chart 9: Age and gender distribution of humeral diaphyseal fractures treated at the Edinburgh
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Chart 10: Age and gender distribution of forearm diaphyseal fractures treated at the Edinburgh
Royal Infirmary between 4th July 2007 and 3rd July 2008
From the above graphs it is noticeable that for both these fracture types the
frequency for females was greater in the above 50 years age group that suggests
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these fractures may be related to post-menopausal osteoporosis. 45(68.2%) of 66
humeral diaphyseal fractures occurred in patients 50 years of age or older, and of
these, greater than two-thirds (31) of fractures were in women. A proportion of these
fractures would have been treated surgically and may have occurred in patients on
bisphosphonate treatment where information on the effects of bisphosphonates on
direct fracture healing may have influenced the trauma surgeon's treatment.
Prospectively collected data from 1364 consecutive patients over the age of 55
years that presented from the community to the Trauma Unit at The Edinburgh Royal
Infirmary with hip fractures between 5th June 2007 to 26th March 2009, revealed that
71 patients (5.2%) were on bisphosphonate treatment prior to their fracture. In line
with current recommendations for secondary prevention of fragility fractures48'49
bisphosphonate uptake is likely to increase. Plated humeral and forearm diaphyseal
fractures of radius and ulna, in patients receiving bisphosphonates may be at
particular risk of non-union. In these patients if a rigid mode of fracture healing is
optimal it may be essential to overcome the local osteoclastic inhibition for instance
by adding bone graft or growth factors
In instances where operative fracture stabilisation is required for fractures in
patients that are already on bisphosphonate treatment, orthopaedic surgeons may
need to consider using non-rigid modes of fixation when possible. The surgeon may
also consider temporarily discontinuing bisphosphonate therapy during the initial
period of direct fracture healing. More importantly, however it is proposed that
bisphosphonate therapy not be commenced immediately after a fracture that is rigidly
fixed.
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The Effect of Bisphosphonate on the Uninjured Contra-lateral
Limb
There is conflicting evidence regarding the effect of bisphosphonates on the
mechanical properties of cortical bone. In growing rats, both a short bisphosphonate
treatment period of three weeks with pamidronate 15and a longer duration of up to
two years with alendronate 85 have been shown to increase femoral cortical strength
in three-point bending stress tests compared to healthy controls. In ovariectomised
rats, three months of clodronate152 and one year of zolendronic acid121 increased
121 152 152femoral ' and tibial cortical bending strength in comparison to sham-
ovariectomised controls. However, six months of alendronate therapy in
ovariectomised rats did not affect femoral diaphyseal strength in bending tests
despite the increased mechanical strength noted in cancellous bone tested in
compression84. Similarly, six months of alendronate120 in castrated male rats did not
increase bending strength of the femur diaphysis, despite the enhanced strength noted
85
previously in ovariectomised rats that received a similar dosing regimen .
The differing results may be because previous studies in rodents have used
ovariectomised84'12'152 castrated, 120 or skeletally immature85'120'151 models.
Following ovariectomy there is increased bone formation in the rat tibial
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diaphysis , and up to six months following ovariectomy tibial bending strength
remains elevated compared to sham-ovariectomised rats152. Therefore, an
ovariectomised model was not used as it may have confounded our results. The
effect of orchidectomy on bone properties are only noted from four months post
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castration onwards l54,155. This factor was not incorporated in to the experimental
protocol of the study by Broulik et al.120 that used castrated animals.
There is no previously published study that has used mature ex-breeder animals
which would be more representative of the situation in routine clinical practice when
bisphosphonates are frequently prescribed for the prevention of fragility fractures in
the elderly population. Skeletally mature animals were also used to eliminate
possible differing bisphosphonate effects on growing bone.
Osteopenia is known to occur during the fracture healing process 76'90. Our results
indicate that ibandronate therapy at a dose known to preserve cancellous bone BMD
and strength141 may increase cortical bone stress at failure. This finding differs to that
previously reported in a beagle dog model of long bone fracture, where alendronate
therapy at a high non-therapeutic dose had no significant effect on the stress at
failure either of the healing fractured radius or the contra-lateral bone70.
This study suggests that within nine weeks of ibandronate therapy the mean stress at
failure of cortical bone is increased by greater than 20%. There was also no
difference in the cortical bone physical dimensions. If the regions of bone that are
undergoing remodelling by osteoclasts are not contributing to the mechanical
strength of the bone, then the rapid increase in bone strength with bisphosphonate
treatment could be accounted for by these regions now being able to contribute to the
strength of the bone, as they are no longer being resorbed by osteoclasts.
A previous study using cortical femoral specimens from human donors reported a
linear relationship between the decrease in bone strength and toughness with
aging156. The authors concluded that in respect to age related change in bone material
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properties the relationship between bone strength and toughness was linear, similar
to that seen in synthetic fibre composites157. In the current study, despite an increase
in bone strength of more than 20% following nine weeks of bisphosphonate therapy,
the bone toughness and work-to-failure was not significantly changed, suggesting
that the energy absorbed per unit of bone prior to failure changed less than the
absolute strength.
Despite the significant positive effect of ibandronate therapy on the stress at failure
of rat tibial diaphyses in bending tests, no statistically significant effect was noted in
the radiological assessment of bone density. This may be due to remodelling areas
not contributing mechanically but still contributing to radiographic bone density.
Alternatively, the mechanical properties may be altered prior to detectable
radiographic change. Whatever the cause for the increase in strength, the observed
bisphosphonate effect on mechanical properties of the uninjured limb needs to be
considered when reporting proportional strength of fracture repair compared to the
unfractured limb.
This study has demonstrated that ibandronate therapy increased the stress at failure
of cortical bone in the uninjured limb in the early phase following a fracture. It is
increasingly evident that a large proportion of osteoporotic fractures occur at non-
vertebral sites where cortical bone is the predominant material present and is due to
the significant cortical bone loss that occurs in osteoporosis 158. The observed
increase in stress at failure of cortical bone with ibandronate treatment is
encouraging. However, the lack of a similar beneficial effect on bone toughness and
work-to-failure should be borne in mind.
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Following prolonged bisphosphonate therapy the adverse effects of
bisphosphonates on bone remodelling, especially in cortical bone78, with the
resultant accumulation of 'microcracks' may make the bone prone to brittle fractures.
This is becoming clinically apparent. In a recent clinical case series, Odvina et al78
reported spontaneous non-vertebral fractures in nine patients on continuous
alendronate treatment for between three to eight years. Five of these patients had
femoral shaft fractures. Bone biopsies from the iliac crest showed reduced surface
osteoclast and osteoblast with decreased tetracycline labelling suggesting impaired
bone turnover. Radiographs revealed delayed bone healing.
The low energy, 'atypical' subtrochanteric femur fracture is emerging as an entity
seen following prolonged alendronate treatment. Goh et al.77 retrospectively
reviewed 13 low energy subtrochanteric femur fractures that presented to their
hospital over a 10 month period in 2007 and noted that nine of these patients were on
continuous alendronate treatment for between 2 V2 to 5 years. They comment on the
distinctive unicortical beaking on the lateral tension surface of the femur and
prodromal thigh pain that may be noticed prior to the fracture. Neviaser et al79
retrospectively reviewed all 70 low energy femoral shaft fractures that presented to
their unit over a five year period. They found that 25(36%) of these fractures
occurred in patients on alendronate therapy. 19(75%) of these 25 patients exhibited a
unicortical beak on radiographs with surrounding cortical hypertrophy.
The effects of longer term bisphosphonate therapy needs further study.
Bisphosphonates have been proven to have a role in fragility fracture prevention,
however an improved understanding of dosing regimens is needed to prevent,





A simple reproducible rodent model of direct fracture healing has been developed.
This model may be used for future studies concerning direct fracture healing.
The results of this study have shown that within 9 weeks of ibandronate therapy the
stress at failure of rodent cortical bone was significantly increased compared to
controls that received a placebo. This bisphosphonate related increase in the strength
of the contra-lateral limb should be considered when reporting the strength of
fracture repair. Commonly the mechanical testing results of fracture repair are
reported as a proportion to that of the uninjured limb. Changes in the uninjured limb
could therefore confound the results of fracture repair when expressed as a ratio.
In the rodent model, ibandronate therapy inhibited direct fracture healing. This was
demonstrated based on mechanical testing, on the appearance of plain radiographs
and on histological analysis. This has implications for the orthopaedic surgeon on
the choice of surgical fixation method during the operative stabilisation of fractures
in patients that are on bisphosphonate therapy.
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The effect of timing of bisphosphonate administration relative to the direct fracture
healing process is not known. Orthopaedic surgeons face the clinical scenario of
patients already on bisphosphonate therapy prior to fracture that requires rigid
plating. The surgeon will need to decide on whether discontinuing bisphosphonate
treatment prior to surgery will eliminate its inhibitory effect on direct fracture
healing or whether a non-rigid fixation modality should be used. Further
investigation is required to ascertain if there is any worthwhile recovery of osteoclast
function in animals already on bisphosphonates when they fracture provided the
bisphosphonate is stopped at the time of fracture. In situations where rigid fixation is
essential in patients on bisphosphonate treatment local or systemic adjuncts to reduce
its negative effect on direct fracture healing will require study.
Further study is required to assess commencement of bisphosphonate therapy post
rigid fracture fixation to investigate the clinical scenario where a patient who is not
on bisphosphonates sustains a fragility fracture and the treating surgeon needs to
decide whether early commencement of bisphosphonate as secondary fracture
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Appendix 1: Specimen Automated Processing Protocol
Specimens processed in Vacuum Infiltrated Processor (VIP, Tissue Tech VIP, E300
series, Miles Inc)
Alcohol 50%, 2 hours at 35°C
Alcohol 80%, 1 hour at 35°C
Alcohol 95% lhour at 35°C
Alcohol 100% lhour at 35°C
Alcohol 100% lhour at 35°C
Alcohol 100% 2 hours at 35°C
Xylene 100%, 3 changes of lhour each
Paraffin, 4 changes of 1 hour each at 60°C
Specimens moulded in paraffin blocks
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Appendix 2: Mechanical Testing Measurements
H - Histology
A - Abnormal (non-bending) Failure Mode






































































































































































































































































































































































































































































units)2 weeks 4 weeks 6 weeks
CX01 1.31 1.57 1.57 4.405 4.67
CX02 1.00 1.14 1.48 3.883 3.6
CX03 1.00 1.52 1.65 5.385 5.73
CX04 1.05 1.40 1.61 5.803 7.73
CX05 1.00 1.41 1.60 5.803 5.6
CX06 1.00 1.36 1.56 5.064 5.17
CX07 1.00 1.38 1.60 4.8 4.8
CX08 1.00 1.38 1.57 5.192 4.03
SX01 1.46 2.04 1.33 5.636 5.87
SX02 1.00 1.27 1.36 4.418 5.47
SX03 1.06 1.24 1.11 3.883 3.2
SX04 1.19 1.59 1.13 4.754 4.83
SX07 1.00 1.15 1.13 3.406 3.6
SX08 1.36 1.73 1.60 4.817 4.73
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Occasion First Second First Second
Animal
C01 2 2 2 2
C03 1 1 1 1
C04 2 2 2 2
C05 1 1 1 1
C06 1 1 1 2
C07 2 2 2 2
C08 2 2 1 2
C09 2 2 2 2
C10 1 1 1 1
CX01 2 2 2 2
CX02 2 2 2 2
CX03 1 1 2 1
CX04 1 1 1 1
CX05 1 1 1 2
CX06 1 2 1 1
CX07 1 1 0 1
CX08 2 2 2 2
S02 1 1 1 1
S03 0 1 0 1
S04 0 0 0 0
S05 1 1 0 0
S06 1 1 1 1
S07 0 0 0 0
S08 1 1 1 1
S09 0 0 0 0
S10 0 0 0 0
SX01 1 1 1 1
SX02 1 1 1 1
SX03 2 2 2 1
SX04 2 2 1 2
SX07 2 2 2 1
SX08 2 1 1 1
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Appendix 5: Animal Weights
Weight Weight
at at
Fracture Sacrifice
Animal (g) (g)
C01 468 475
C02 611 617
C03 475 467
C04 477 480
C05 450 476
C06 479 516
C07 456 483
C08 475 492
C09 527 529
C10 421 439
CX01 438 463
CX02 454 450
CX03 456 477
CX04 601 603
CX05 468 462
CX06 483 481
CX07 514 533
CX08 492 481
S01 524 516
S02 522 510
S03 510 509
S04 500 494
S05 525 519
S06 536 552
S07 482 495
S08 532 540
S09 527 519
S10 472 465
SX01 416 410
SX02 519 507
SX03 441 448
SX04 504 508
SX05 494 501
SX06 577 559
SX07 576 545
SX08 475 489
 
